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Aminoglycoside antibiotics are powerful drugs for combating bacterial infections,
but are limited in use due to their ototoxicity. This class of drug targets the auditory hair
cells of the cochlea, causing cell death, which leads to a decline in auditory function. In
spite of much research aimed at revealing a mechanism of damage, there are no cotherapies available to diminish the ototoxic liability of aminoglycosides. Existing
research does show that there may be a neurodegenerative process that contributes to the
observed toxicity. In an effort towards clarifying present understanding of issue, this
dissertation project was conducted to characterize the neurodegenerative effects of
kanamycin, a commonly used aminoglycoside antibiotic. Specifically we assessed the
effects of kanamycin on inner hair cell ribbon synapse degeneration and plasticity in the
guinea pig.
The project first identified the drug concentration and number of doses necessary
to induce the desired effect, loss of inner hair cell ribbons. The kanamycin dosing
regimen employed produced significant high frequency hearing loss with associated outer
hair cell loss 14 days following the last administration. Although there was no inner hair
cell loss at this time, treatment caused significant decreases in inner hair cell ribbons in
the furthest basal regions of the cochlea. The next phase of the project examined how
ribbon densities changed over time following kanamycin administration. Here, results

demonstrated that doses of kanamycin administered for 10 consecutive days generated
significant reductions in ribbon densities acutely, followed thereafter by ribbon
regeneration. The hearing deficits and outer hair cell losses, in addition the severity of
the ribbon density changes were more severe with the increased dosage. Interestingly,
the postsynaptic spiral ganglion neurons were not affected at 56 days from the last dose.
The next project specifically looked at how kanamycin affected the inner hair cell ribbon
and associated postsynaptic glutamate receptors. The results showed similar synaptic
loss following dosing and confirmed that synaptic regeneration occurs over time. The
final experiment in this series looked at how intra-aural gentamicin affects synapse
densities acutely. The results indicate that intra-aural administration produces greater
synaptic losses throughout the cochlea as compared to systemic administration. In
conclusion, this project established the role of synaptopathic effects of aminoglycoside
ototoxicity, and additionally illustrated the capacity for regeneration following the initial
expression of such ototoxicity.
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CHAPTER I
INTRODUCTION
Physiology of Hearing
Hearing is an important sense to possess as it facilitates communication, spatial
orientation, and enables survival by detecting noises around us. Sound stimuli from our
environment pass through the external ear into the middle ear where these are amplified
by the tympanum and ossicles and transmitted into the inner ear (Møller, 2006). The
cochlea of the inner ear is a fluid filled compartment which is separated into three
chambers, the scala tympani, scala vestibuli, and scala media. The scala vestibuli and
tympani are filled with a fluid call perilymph that is mainly characterized by high
concentrations of sodium and low concentrations of potassium. The scala media is filled
with endolymph which in contrast perilymph contains high levels of potassium and low
levels of sodium. This ion gradient is actively maintained by sodium potassium pumps
located in the stria vascularius (Roland and Rutka, 2004), and is an important feature
allowing stimulus transduction.
The scala media contains a specialized organ called the organ of Corti. The
organ of Corti contains thousands of specialized auditory sensory receptors (hair cells)
that are differentiated by type according to their location and function. The outer hair
cells are located in three organized rows along the basilar membrane, and act to help
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direct active tuning of specific frequencies. The inner hair cells are organized in a single
row along the inside of the basilar membrane and are responsible for ~95 of afferent
neurotransmission (Pickles, 2012).
One conserved feature of all auditory hair cells (inner and outer) is the presence of
stereocilia. As sound waves move into the cochlea, pressure waves are created in the
perilymph which transmits shearing forces on the stereocilia. As the stereocilia are
deflected, potassium ions enter the cell through mechanotransduction channels,
ultimately causing cellular depolarization (Pickles, 2012). Depolarization of the outer
hair cells causes the cells to change in length (Brownell, 1990). This electromotility is
thought to enhance sensitivity of selected frequencies (Dallos and Evans, 1995). Each
outer hair cell varies in length and is “tuned” to a specific frequency of vibration and thus
enhances pressure waves of a specific frequency as they move through the cochlea while
other adjacent outer hair cells help dampen off-frequency pressure waves (Canlon et al.,
1988).
The outer hair cell enhanced motion of the basilar membrane causes the
associated inner hair cell to depolarize, which in turn causes afferent neurotransmission.
More specifically, the inner hair cell depolarization causes voltage-dependent calcium
channels to open, and the influx of intracellular calcium facilitates neurotransmitter
release (Brandt et al., 2003). The inner hair cell possesses ribbon structures at the base of
the cell which maintain and hold stores of neurotransmitter filled vesicles (Schmidtz,
2009). The fusion and release of these vesicles is calcium dependent providing a
mechanism for coordinated and sustained release in response to different intensity stimuli
2

(Johnson et al., 2008). This function is critical in maintaining temporal resolution during
normal hearing.
It has been shown that the afferent nervous system of the inner ear depends upon
glutamateurgic neurotransmission. Specifically, inner hair cells release glutamate into
the active zone of the afferent processes of the Type I spiral ganglia cells (Coate and
Kelly, 2013). These Type I spiral ganglia cells are only connected to the inner hair cells
and are myelinated. Type II spiral ganglia cells are a minor part of the total population
and innervate only the outer hair cells. The afferent processes of the Type I spiral ganglia
cells are depolarized when glutamate binds to AMPA and kainate receptors on their
membrane surface (Peppi et al., 2012; Ruel et al., 1999). These spiral ganglion neurons
transmit chemical signals up through the cochlear nerve to the cochlear nucleus and via
other neurons to higher order centers of the auditory pathway where sound is processed
and interpreted.

Aminoglycoside Ototoxicity

Aminoglycoside antibiotics are valuable antimicrobial tools used for the treatment
of gram-negative bacterial infections (Mingeot-Leclercq et al. 1999). The bactericidal
effectiveness of these drugs has led to their use for the treatment of serious illnesses such
as multi-drug resistant tuberculosis (ATS-CDC, 1993). In addition to their effectivveness
in treating disease, these drugs are relatively inexpensive, and therefore are widely used
in developing countries for treatment of less serious infections. The primary mechanism
3

of action of these compounds is to disrupt protein synthesis by means of binding to the
16S rRNA, which causes early cessation of translational activity, and/or translational
misreading (Mingeot-Leclercq et al. 1999).
The dose and frequency of administration of these type drugs is limited by well
documented oto- and nephro-toxicities (Dwivedi et al. 2009; Song et al. 1997; Jiang et al.
2005). Evidence of ototoxicity was clear early-on, as a paper published in 1959 reported
that 80% of Kanamycin-treated tuberculosis patients had hearing loss that was not present
before treatment (Brouet et al, 1959). Preventing these unwanted side-effects would
enable less constringent use of these compounds, which may augment the spectrum of
their clinical applications. Given the low cost of this class of anti-infective, this could
have a major impact on health care costs in developed countries and positively impact
quality of life in developing countries.
The ototoxicity associated with aminoglycoside administration is characterized by
a loss of the auditory hair cells and interrelated/connected neural components. The
events leading to the eventual loss of these cell types is characterized below in support of
the specific aims of this project.
Aminoglycoside Uptake in Hair Cells
Aminoglycosides begin exerting toxic effects when they cross the blood-labyrinth
barrier and enter the endolymph of the cochlea and vestibule. This process begins when
aminoglycosides are administered systemically and the drug molecules travel through the
blood stream to the capillaries of the stria vascularis (Dai and Steyger, 2008).
Aminoglycosides exit the endothelial cells of the capillaries and then enter the
4

endolymph through the marginal cells of the intrastrial space beginning in the basal turn
of the cochlea (Steyger and Karasawa, 2008; Dai and Steyger, 2008; Dai et al., 2006).
Once in the endolymph, the aminoglycoside molecules enter the inner and outer
hair cells via three different mechanisms. First, the aminoglycoside molecules have been
shown to enter and subsequently block the mechano-electric transducer (MET) channels
on the stereocilia of the outer and inner hair cells (Marcotti et al., 2005; Kimitsuki et al.,
2001; Steyger et al. 2003; Gale et al. 2001; Owens et al, 2009). A second mechanism of
entry is believed to originate from the aminoglycoside molecules binding with specific
receptors on the cell surface, thus promoting endocytosis (Hasino and Shero, 1995;
Steyger et al. 2003). Once inside the hair cells, intracellular trafficking of
aminoglycoside-filled endosomes results in distribution of the aminoglycosides
molecules into lysosomes, the Golgi apparatus, mitochondria, the nucleus, and the
endoplasmic reticulum. The third and final mechanism of entry originates from data
suggesting that aminoglycosides enter hair cells via non-selective cation channels;
specifically transient receptor potential channel subtype vallinoid (Karasawa et al., 2008;
Li and Steyger, 2009). This type of channel entry is supported by data showing that
TRPV channel blockers decrease auditory hair cell uptake of fluorescent aminoglycosides
in a dose-dependent manner (Lee et al., 2013).
Induction of Apoptosis by Aminoglycosides
Once the drug enters the auditory hair cells, the aminoglycoside molecules induce
hair cell apoptosis. The typical pathology associated with aminoglycosides begins with
the outer hair cells of the basal turn being initially affected with damage progressing to
5

the inner hair cells, gradually along the cochlear length (Fee, 1980). There exists strong
evidence that the events leading to apoptosis are attributable to the production of reactive
oxygen species (ROS) (Song et al. 1997; Parlakpinar et al. 2004; Sha and Schacht 1999;
Priuska and Schacht 1995; Wang et al., 2003). Once inside the cell, the aminoglycoside
molecule binds with free iron to create a redox-active complex which catalyzes the
formation of ROS (O2, H2O2, OH, and ONOO-) subsequently reducing proteins and
phospholipids (Jiang et al. 2005, Chen et al. 2007; McFadden et al., 2003). Increased
production of these free radicals is supported by studies showing increased production of
cochlear xanthine oxidase, nitric oxide (NO) synthase II, and decrease levels of
glutathione, glutathione reductase, and glutathione peroxidase following aminoglycoside
exposure (Takumida et al. 1999, 2003; Rybak et al., 2000). Interestingly, the graded
difference in aminoglycoside associated hair cell loss between the apex and basal regions
of the cochlea has been attributed to the higher levels of glutathione in the apical hair
cells (Sha et al. 2000). The pivotal role that ROS play in aminoglycoside ototoxicity is
further supported by the ameliorating effects that free radical scavengers and iron
chelators produce in the context of aminoglycoside challenge (Conlon et al., 1999; Wang
et al., 2003; Chen et al., 2007; LePrell et al., 2007; McFadden et al., 2003; Song et al.,
1997; Fetoni et al., 2003).
The production of excess ROS disrupts hair cell homeostatic functioning, leading
to a stressed cellular environment. Evidence suggests that aminoglycoside-associated
hair cell death, in part, originates from the phosphorylation of c-Jun N-terminal kinase
(JNK), a stress-induced MAP kinase (Wang et al., 2003; Ylikoski et al., 2002). Stresses
6

associated with the activation of this type of MAP kinase include changes in temperature
and pH, and more importantly increases in free radicals (Davis, 2000). Increases in
reactive oxygen species following aminoglycoside administration have been well
documented, and may act as the major triggering event leading to apoptosis (Forge and
Schacht 2000; Sha and Schacht 1999, Lesniak et al. 2005). Following phosphorylation,
the JNK kinase promotes differential regulation of the Bcl-2 family of genes, which
consist of pro- and anti-apoptotic proteins (Cheng et al., 2005). The proapoptotic Bcl-2
proteins that have been shown to increase during hair cell death are Bax, Bak, Bid, Bad,
and Bim (Cheng et al. 2005). Conversely, the anti-apoptotic proteins Bcl-2 and Bcl-XL
have been shown to decrease following drug treatment (Cheng et al. 2005; Abi-Hachem
et al., 2010). The balance of these proteins acts as the determining factor promoting or
inhibiting apoptosis. When the protein balance shifts towards proapoptosis, the Bax
protein forms pores in the mitochondrial membrane subsequently causing the release of
cytochrome C and free radicals (Cheng et al. 2005; Van De Water et al., 2004). The
release of these free radicals adds to the oxidative insult already generated by the
presence of the aminoglycosides. Free cytochrome C binds with apoptotic protease
activating factor (APAF-1), dATP, and procaspase 9 to form the apoptosome (Van De
Water et al., 2004). The apoptosome initiates the cleavage of procaspase 9 to form
activated caspase 9 (Eshraghi et al., 2007; Van De Water et al., 2004). Once activated,
caspase 9 activates caspase 3 (Davis, 2000; Hu et al., 2008, Dehne et al 2002). Caspase 3
is an effector caspase and is ultimately responsible for executing cell death. This caspase
protein first acts to remove select apoptosis inhibitory proteins (IAPs) (Van De Water et
7

al., 2004). After removal of these select proteins, caspase 3 promotes cell death by
degrading proteins such as poly (ADP-ribose) polymerase (PARP-1), DNA
topoisomerase, and transducer/activator of transcription-1, which all involve cellular
repair and protein synthesis (Jiang et al., 2006; Van De Water et al., 2004). Inactivation
of these types of proteins results in nuclear condensation and fragmentation, which
represents the final stages of apoptosis (Hu et al. 2008).
There is also evidence to suggest that ROS may additionally trigger cell death via
caspase-independent mechanisms. As suggested above, aminoglycosides can enter the
cell and create ROS, which subsequently attack cell and organelle membranes. In the
case of the mitochondria, membrane disturbances can cause the release of apoptosisinducing factor (AIF) and endonuclease G (Endo G) (Jiang et al., 2006). Endo G is a
Dnase, which once released from the mitochondria can enter the nucleus and cause DNA
fragmentation (Li et al., 2001). AIF acts similarly when released from the mitochondria
as it translocates to the nucleus and causes chromatin condensation and DNA
fragmentation (Cande et al., 2002). Other studies have indicated that the influx of
calcium associated with aminoglycoside administration results in the activation of
Calpains, a class of calcium dependent proteases (Momiyama et al., 2006; Jiang et al.,
2006). Once activated, calpains can bind to lysosomal membranes and cause the release
of cathepsins (Jiang et al., 2006). Cathepsins cleave PARP-1 (like caspase 3), which in
turn initiates cell death (Syntichaki et al., 2002). The role of calpain activity in AGA
associated hair cell death is supported by the prevention of hair cell loss in-vivo with
administration of Leupeptin, a calpain inhibitor (Momiyama et al., 2006).
8

Interestingly beyond caspase-dependent and caspase-independent processes, there
is a third postulated mechanism of cellular death (incorporating aspects of each of the
above mechanisms) which involves reactive nitrogen species (RNS). Limited research
exists about this pathway, but its contribution to the overall damage induced by
aminoglycoside administration has been established by several studies. RNS production
is believed to originate from excessive NMDA receptor activation (Segal et al., 1999;
Basile et al., 1996; Takumida and Anniko, 2000). The polyamine-like structure of
aminoglycosides has been shown to enable binding and subsequent activation of NMDA
receptors (Pullan et al., 1992). In the presence of aminoglycosides, NDMA and nonNMDA (AMPA and Kainate) type receptors are activated which in turn facilitate massive
Ca2+ entry into the auditory cell and spiral ganglion neurons (Takumida et al, 1999). It
is proposed that the presence of high levels of Ca2+ induce the expression of nitrogen
oxide synthase II (NOS II), which is capable of producing large quantities of nitrogen
oxide (NO) (Takimuda et al., 1999; Takimuda and Anniko, 2000). NO quickly binds
with superoxide molecules to form peroxynitrite (Takumida et al., 1999). Peroxynitrite is
highly reactive and modifies proteins containing the amino acid tyrosine, e.g. actin and
neurofilaments, and activates downstream cell death pathways (Takumida et al., 1999).
There is evidence showing that prevention of peroxynitrite formation via administration
of NMDA receptor antagonists and peroxynitrite scavengers is efficacious at reducing
aminoglycoside ototoxicity (Takumida et al., 2001; Takumida and Anniko, 2000; Segal et
al., 1999; Basile et al., 1999; Duan et al., 2000).
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Impact of Ototoxicity on Neurodegeneration

There are multiple studies showing profound neurodegeneration of spiral ganglion
neurons following aminoglycoside administration (Glueckert et al. 2008; Hong et al.,
2006). Again, spiral ganglion cells are connected to the inner hair cells via afferent
peripheral processes, and their central axonal process projects onto cells in the cochlear
nucleus (McGuiness and Shepard, 2005; Spoendlin and Schrott, 1988; Nadol, 1988).
The loss of the spiral ganglion cells following aminoglycoside administration is
secondary to the loss of the afferent peripheral processes and inner hair cell synapses,
which has been shown to occur within 3 days of aminoglycoside/loop diuretic exposure
(Duan et al., 2000; Glueckert et al., 2008). Spiral ganglion cells begin to significantly
degenerate approximately 2 to 5 weeks following a standard 7-day treatment with an
ototoxic dose of kanamycin (Jyung et al, 1989; Poirrier et al., 2010). Due to the length of
time necessary to induce the loss of the spiral ganglion cells, it is generally believed that
the degeneration of these cells is due to a lack of neurotrophic support associated with the
loss of inner hair cells and/or damage to support cells (Duan et al., 2000; McFadden et
al., 2004; Mattson and Furukawa, 1998). This hypothesis is supported by the rescue of
spiral ganglion cells and peripheral processes by administration of various neurotrophic
factors (Miller et al. 2007; McGuiness and Shepard 2005; Miller et al., 1997).
The neurodegeneration observed following many cochlear pathologies has been
shown to originate with the loss of the inner hair cell synapse. The presynaptic inner hair
cell ribbon is responsible for coordinated glutamate release onto afferent spiral ganglion
10

processes which is necessary for precise temporal resolution during audition. The inner
hair cell ribbon is composed of multiple proteins that act as a scaffold for the glutamate
filled vesicles (Zanazzi and Matthews, 2009). The activation of these ribbon structures
has been linked to voltage gated L-type calcium channels, which are believed to enable
sustained neurotransmitter release (Meyer et al., 2009). In the case of noise trauma,
glutamate is released in large quantities, which then activates the postsynaptic NMDA
receptors causing massive sodium and water entry into the afferent neurons (Puel et al.,
1997). It has been reported that within 24 hours of noise trauma, over half of the ribbon
structures and afferent processes are completely degenerated (Kujawa and Liberman,
2009).
Kujawa and Liberman (2009) reported that synapse ribbon structures decline in
numbers following a noise insult, but the auditory deficits incurred are temporary as
threshold sensitivity returns to baseline levels weeks after the insult. In their study,
auditory function recovered and no hair cell losses were observed but the ribbons
structures were lost permanently. At 1 and 2 years following the injury, the inner hair
cells were found to be still intact, however, substantial losses in spiral ganglion cells were
observed.
Similarly in terms of response to cochlear trauma, Chen et al. (2013) showed that
inner hair cell ribbon synapse densities decrease acutely following repeated
aminoglycoside administration in mice. There have been several other studies that have
provided insights into the effects of aminoglycosides on inner hair cell
neurotransmission. For instance, a recent study found that expression of the vesicle
11

fusion protein, Otoferlin, is up-regulated in mice during a standard course of
aminoglycoside treatment (ShuNa et al., 2009). Otoferlin is an essential transmembrane
protein found in inner hair cells that facilitates vesicle exocytosis, and when absent leads
to severe deafness (Roux et al., 2006). Of particular importance is the fact that Otoferlin
facilitates glutamate vesicle exocytosis in a calcium-dependent manner (Ramakrishnan et
al., 2014). It has been suggested that in the presence of aminoglycosides, NDMA and
non-NMDA (AMPA and Kainite) type receptors are activated which in turn facilitate
massive Ca2+ entry into inner hair cells (Takumida et al, 1999). This hypothesis is
supported by the sparing of inner and outer hair cells by administration of leupeptin, a
calcium-activated protease inhibitor, in models of aminoglycoside ototoxicity (Ding et
al., 2002; Momiyama et al., 2006). Together, these data suggest that aminoglycosides
induce calcium entry into the inner hair cell via NMDA receptors, which in turn increase
the activity/expression of Otoferlin.
Understanding the time course of effects of aminoglycosides on ribbon synapse
densities in relation to inner hair cell and spiral ganglion loss, would provide critical
insight into the long-term ramifications of aminoglycoside use on auditory
neurotransmission. If found that aminoglycosides induce inner hair cell synapse density
decreases with only a mild effect on hair cell viability, the hearing loss observed
following use may involve a major neurodegenerative processes that has not been
considered when developing treatments to prevent this unwanted side effect.
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Specific Aims
The specific aim of this dissertation project was to understand the effects of
kanamycin on inner hair cell synapse plasticity. It was the goal of the project to
understand how different concentrations of the drug affect inner hair cell synapse
densities. It was also a goal to understand if synaptic degeneration occurs overtime and
how this affects spiral ganglion viability.
Specific Aim 1:
Test the hypothesis that kanamycin treatment will result in a dose-dependent decline in
the number of synaptic structures, as represented by the presence of presynaptic ribbons.

Specific Aim 2:
Test the hypothesis that a low dose of kanamycin, e.g. a dose capable of inducing outer
hair cell loss without inner hair cell loss, will cause a loss of synaptic structures without
loss of the corresponding inner hair cells.

Specific Aim 3:
Test the hypothesis that inner hair cell synapse degeneration without inner hair cell death
eventually leads to spiral ganglion cell death.
Specific Aim 4:
Test the hypothesis that the concentration of aminoglycosides in the perilymph of the
cochlea impacts the timing and severity of synaptic loss observed.
13
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CHAPTER II
CHARACTERIZATION OF INNER HAIR CELL RIBBON
DENSITIES THROUGHOUT THE COCHLEA FOLLOWING 7
DAYS OF KANAMCYIN EXPOSURE
Introduction
It has been well demonstrated that prolonged exposure to systemic
aminoglycoside antibiotics can cause ototoxicity in many species. Given this type of
compound’s potent bactericidal properties, much effort has been exerted to ameliorate
this adverse side-effect. As indicated in the introduction to this dissertation, it is believed
that aminoglycosides form metabolites that cause cellular stress, ultimately leading to
apoptosis. Interestingly, there have been many different types of therapies developed
with the aim of decreasing cellular stress, e.g. antioxidants, in efforts to reduce this
ototoxicity (Le Prell et al.,2014; Ojano-Dirain et al., 2014; Fetoni et al., 2012; Wang et
al., 2003). Although moderate hair cell sparing has been reported, these results further
suggest that the mechanism is more complex than originally thought.
Aminoglycoside ototoxicity has been shown to have dose dependent properties
with regard to the auditory functional deficits and hair cell toxicity (Montalbano et al.,
2014; Gong et al., 2012; Maniu et al., 2011). The outer hair cells appear most sensitive to
drug treatment followed by the inner hair cells (Schmitz et al., 2014; Ye et al., 2009).
Interestingly, the outer hair cells within the base of the cochlea are more sensitive to
aminoglycosides than the hair cells in the mid and apical regions, a finding which may be
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related to endogenous mechanisms of stress handling (Choung et al., 2009; Wu et al.,
2002; Sha et al., 2001). The inner hair cell is responsible for the majority of
neurotransmission and it has been shown that once inner hair cells die, associated spiral
ganglion cells degenerate (Safieddine et al., 2012; van Loon et al., 2013; Bae et al.,
2008). It has been proposed that inner hair cells and cochlear support cells produce
neurotrophins which maintain nerve viability, and therefore the loss of these cells
contribute to secondary nerve degeneration (Yu et al., 2013; Miller et al., 1997).
There are other types of cochlear insults that produce ototoxicity and nerve
degeneration similar to that observed with aminoglycosides. Acoustic overexposure, a
mechanism of noise- induced cochlear damage, has been shown to cause robust hair cell
loss and afferent neuron degeneration (Bielefeld et al., 2011; Park et al, 2013; Wang and
Ren, 2012; Kujawa and Liberman, 2006).

Kujawa and Liberman (2009) reported that

synapse ribbon structures in mice decline in numbers following a noise insult, resulting in
a temporary auditory threshold shift that resolved several days following the injury.
Following this type of injury, the ribbon structures were lost without corresponding
catastrophic change to the inner hair cell; the mechanism of this selective sub-cellular
modification was thought to be excessive glutamate release. When assessed 1 and 2
years following the injury, the inner hair cells were found to be still intact, however,
substantial losses in spiral ganglion cells were observed. Lin et al. (2011) confirmed that
the same neural degeneration following noise-induced temporary threshold shifts occurs
in the guinea pig.
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No similar data exist characterizing the effects of nominal doses of AGAs on
glutamate ribbons in the guinea pig. The similarity of cell-death pathways involved in
noise- and aminoglycoside-induced pathology allow us to hypothesize that such a
mechanism (e.g., low dose AGA treatment) will result in loss of synapses and spiral
ganglion cells without the loss of inner hair cells. This study was conducted in an
attempt to establish that presynaptic ribbon densities decrease in the guinea pig following
aminoglycoside exposure, and to define the distribution of the decrease in inner hair cell
ribbon density along the length of the cochlea. Our results indicate that high doses of
aminoglycosides produce significant inner hair cell ribbon density decreases in the basal
region of the guinea pig cochlea.

Methods
Subjects
All animal use and the study protocol were approved by the Institutional Animal
Care and Use Committee at MPI Research Inc., a fully AALAC-accredited research
facility. Twenty male albino Hartley guinea pigs (Charles River laboratories, MI) were
placed on study at 8 weeks of age. The animals were single housed in wire mesh caging
and provided environmental enrichments. All subjects were placed on ad libitum access
to both food and water and weighed between 200 and 400 g at the initiation of the
experiment. The room was temperature and humidity regulated with fluorescent lighting
provided on a 12 hour light/dark cycle (0600h – 1800h). Clinical observations were
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conducted twice daily by AALAS-accredited research technicians that monitored food
and water access as well as the general health and wellbeing of the animals.
Study Design
Twenty guinea pigs were placed into treatment groups of 5 animals per group.
The animals received subcutaneous (SC) injections of saline, or kanamycin at 100, 200,
or 400 mg/kg once daily for 7 consecutive days. The animals were allowed a 14-day
recovery period prior to euthanasia. Kanamycin sulfate (Sigma Aldrich, MO) was
formulated as an 80 mg/ml solution in normal sterile saline USP (0.9% sodium chloride).
Normal sterile saline USP (Sigma Aldrich, MO) and formulated kanamycin doses were
administered subcutaneously at a volume equivalent of 5 ml/kg. The animals were
allowed a 14-day recovery period prior to euthanasia.
Auditory Brainstem Response (ABR) Evaluations
All animals underwent bilateral auditory brainstem response (ABR) evaluations at
4, 10, and 20 kHz prior to being assigned to study, and on the day prior to euthanasia.
The sound presentation was generated using an RZ6 multi I/O processor (TDT
Technologies, FL). The animals were anesthetized with an intraperitoneal drug
combination of 40 mg/kg ketamine hydrochloride (100 mg/ml) and 0.25 mg/kg of
dexmedetomidine (0.50 mg/ml). Once a stable plane of anesthesia was confirmed as a
loss of pain reflex, the animals were placed in the prone position within an electrically
shielded sound attenuation chamber. Pin lead electrodes were placed to collect the ABR
biopotential data. The lead configuration used to collect the electrophysiological data
consisted of a positive lead under the target ear, a reference lead at the vertex of the skull,
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and a ground lead under the contralateral ear. The terminal ends of the pin leads were
connected to a Medusa preamplifier with a 20X gain and a 4-channel headstage (TDT
Technologies, FL). The stimulus used to elicit the ABR waveform was a 15 ms pure tone
pip with a 1 ms rise/fall time. The tone pips were delivered at a rate of 10 cycles per
second through a MF-1 transducer (TDT Technologies, FL). The stimulus intensity was
attenuated in 10 dB steps beginning at 80 dB SPL. The biopotential data were averaged
across the 512 stimulus presentations for each intensity level. An auditory threshold was
defined as the minimal sound pressure level showing a reliable waveform with
recognizable elements of the auditory brainstem response.
Tissue Processing
The day following the final ABR evaluation, all animals were euthanized by
anesthesia with intraperitoneal sodium pentobarbital to effect. Whole body intracardiac
perfusion was performed by the application of 0.9% saline followed by 4% w/v
paraformaldehyde. The left and right temporal bones from each animal were harvested.
A small hole was made in the apex of each cochlea and the oval window was perforated
to facilitate intrascalar perfusion of 4% paraformaldehyde. The cochleae were then
stored in a solution of 0.5% paraformaldehyde and placed in refrigerated conditions (2 8°C) until further processing.
The cochleae were dissected to reveal the organ of Corti. The organ of Corti was
then fluorescently stained to identify the auditory hair cells and inner hair cell ribbons.
For staining, the tissues were first placed in a blocking solution consisting of 1% goat
serum (Invitrogen, CA) and 0.3% Triton X-100 in phosphate buffered saline (PBS). The
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cochleae were then incubated overnight in a primary antibody solution of 1:100 mouse
anti-CtBP2 antibody (BD Transduction Laboratories, CA) at 2 - 8°C. The cochleae were
rinsed and then incubated for an hour in a secondary antibody solution containing 1:200
Alexa Fluor® 488 Goat anti-mouse IgG (H+L) antibody (Life Technologies, CA) and
1:200 Alexa Fluor® 568 phalloidin (Life Technologies, CA).
Imaging and Analysis
All tissue imaging was conducted using a Zeiss Axiovert 200M confocal
microscope at 63X magnification. Using a photo reticule, the organs of Corti were
separated into 0.98 mm segments beginning in the apex and z-stack images were captured
for each segment. For image capture, z-stacks were created using a 0.12 µm step size.
The images were deconvolved and saved as individual planes. Each plane per region was
then imported into ImageJ v1.47t for 3D reconstruction. A 3D project was created for
each region allowing 90 degree rotation at the x-axis of the 3D image. Using the cell
counter plugin, the number of CtBP2 ribbons was manually counted at the base of each
inner hair cell. The present and missing outer and inner hair cells were quantified within
each of these regions to assess the severity of drug-induced damage. The CtBP2 ribbon
density per inner hair cell was then calculated for each region by dividing the total ribbon
count by the number of inner hair cells present in the region.

Statistical Analyses
Hair cell counts and inner hair cell ribbon densities were compared between
groups using descriptive statistics (mean ± SD). Each group’s hair cell counts were
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averaged into 0.98 sections. The inner hair cell ribbons were counted and a density
measurement was calculated for each region. The densities (ribbons/hair cell) in each
region were averaged within each animal and then each group. All group comparisons
were conducted using an Analysis of Variance (ANOVA) procedure, followed by a
Tukey post hoc test. All statistical analyses were performed using Graphpad Prism
v4.00.

Results
Auditory Brainstem Response Evaluations
The difference between pretest and postdose thresholds were averaged bilaterally
for each animal and group, and are presented in Figure 1. As expected with this type of
ototoxin, the 400 mg/kg dose of kanamycin produced a significantly increased 20 kHz
threshold of 38.10 ± 16.63 (p≤0.01). The thresholds for the 4 and 10 kHz frequencies
within the 400 mg/kg dose group were unaffected, presenting with averages that were
similar to pretest and control values. The 100 and 200 mg/kg kanamycin doses did not
significantly affect any of the thresholds for the frequencies assessed on study.
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Figure 1. Effects of kanamycin administration on auditory threshold.

Auditory Hair Cell Analysis
The hair cell histology data for each group are presented in Figure 2. The number
of missing outer and inner auditory hair cells were averaged into 0.98 mm segments
beginning in the apex of the cochlea and are presented as successive regions. The 100
and 200 mg/kg dose groups displayed limited to minor damage to the outer and inner hair
cells throughout the cochlea. In contrast, the 400 mg/kg dose caused significant damage
to the outer hair cells beginning in region 13 and continuing through region 17.
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Additionally in the 400 mg/kg dose group, some minor inner hair cell damage was
detected beginning in region 14 and continuing through region 17. The outer hair cell
damage observed in this dose group tonotopically supported a sensorineural basis for the
observed 20 kHz ABR threshold shift.
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Figure 2. Effects of kanamycin administration on hair cells.

Inner Hair Cell Ribbon Density
The inner hair cell ribbon densities were calculated every 0.98 mm. The average
ribbon density was analyzed in successive regions beginning in the apex. Analysis of the
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inner hair cell ribbon density data revealed moderate density decreases within the lower
basal regions of the 400 mg/kg dose group (see Figure 3). The 400 mg/kg dose group’s
ribbon densities significantly decreased by 35% in region 16 and 36% in region 17 when
compared to control and the 200 mg/kg dose group (p<0.05). Table 1 shows the average
inner hair cell ribbon density for each region of the cochlea in each group. The densities
from the control group showed minor variability throughout the entire cochlea. There
were no significant differences in density observed in any part of the cochlea in the 100
and 200 mg/kg dose groups as compared to control.
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Figure 3. Effects of kanamycin administration on inner hair cell ribbon density.
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Table 1
Inner Hair Cell Ribbon Densities by Cochlear Region
Inner Hair Cell Ribbon Density (mean ± S.D.)
Cochlear
Region

Control

200 mg/kg

400 mg/kg

1

20.64 ± 2.16

20.91 ± 3.09

17.50 ± 1.61

2

24.28 ± 6.01

22.62 ± 4.07

20.75 ± 2.48

3

19.27 ± 1.45

21.74 ± 2.19

21.09 ± 4.51

4

19.97 ± 2.46

22.41 ± 2.25

19.75 ± 4.65

5

22.40 ± 4.41

21.08 ± 4.81

18.42 ± 5.30

6

19.54 ± 3.13

22.44 ± 4.15

18.83 ± 1.33

7

20.08 ± 2.20

23.58 ± 4.40

20.43 ± 2.76

8

21.17 ± 2.59

22.75 ± 3.87

21.13 ± 4.68

9

19.42 ± 2.30

23.61 ± 3.89

21.44 ± 1.93

10

20.70 ± 3.02

22.97 ± 3.74

22.27 ± 1.95

11

17.29 ± 3.18

22.24 ± 2.87

17.82 ± 2.66

12

20.54 ± 1.22

23.52 ± 3.52

21.86 ± 2.82

13

22.03 ± 1.38

24.03 ± 3.90

23.27 ± 1.50

14

23.22 ± 4.46

25.18 ± 4.47

20.08 ± 2.54

15

23.04 ± 4.53

23.71 ± 3.03

20.94 ± 4.71

16

21.58 ± 5.89

22.53 ± 3.92

14.19 ± 3.28

17

20.24 ± 3.87

22.75 ± 5.24

12.99 ± 3.79

18

17.84 ± 0.00

15.11 ± 0.00

12.29 ± 1.88
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Discussion
The results of this study show that high doses of kanamycin produce significant
reductions in inner hair cell presynaptic ribbons within the basal region of the cochlea.
The highest dose of kanamycin used on study produced high frequency hearing loss with
associated tonotopically consistent outer hair cell loss and no inner hair cell loss. The
lower doses of kanamycin tested produced no functional deficits, hair cell loss, or ribbon
density decreases. Interestingly, the regions that produced the most significant decreases
in ribbon densities were associated with robust outer hair cell losses.
Important aspects of this study are the dose concentration, number of doses, and
recovery period selected for use. The 400 mg/kg dose of kanamycin was selected based
on numerous articles documenting the capacity of this dose to produce profound hair and
spiral ganglion cell loss (Arpini et al. 1979; Hangfu et al. 1992; Song et al. 1998; Brown
et al. 1980; Toyoda and Tachibana 1978; Poirrier et al. 2010; Yamane et al. 1983; Ishii et
al. 1968; Hawkins and Engstrom 1964; Dallos and Wang, 1974). The 100 and 200 mg/kg
doses of kanamycin are half and quarter concentrations of the high dose, and were
selected to produce minimal ototoxicity in an effort to mimic a benign noise exposure.
The number of doses and the timing of the study were specifically designed to
elicit a maximal response in the auditory hair cells. Each drug dose was administered for
seven consecutive days to reflect a clinically relevant treatment time course. It has been
shown that systemically administered aminoglycosides distribute to the perilymph of the
inner ear (Li and Steyger, 2011; Wang and Steyger, 2009, Imamura and Adams, 2003).
The clearance kinetics of these drugs in the inner ear differ from the systemic circulation
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in that the drug persists much longer in the inner ear (Hiel et al., 1992). Given the
persistence of drug in the inner ear, multiple days of dosing reliably causes the drug to
accumulate and increase in concentration in the endolymph surrounding the auditory hair
cells (Erdem et al., 2005). We allowed a 14 day recovery after dosing and prior to the
terminal assessments as this approach has been shown to elicit reproducible hair cell
toxicity putatively due to the increased time of exposure (Pavlidis et al., 2014).
Another critical design consideration for characterizing inner hair cell ribbon
degeneration following aminoglycoside administration was the use of guinea pigs. The
guinea pig was selected to assess the effects of aminoglycosides on inner hair cell ribbon
densities because this model has been shown to be highly sensitive to ototoxin therapies
(Shi et al., 2014; Kashio et al., 2012, Poirrier et al., 2010). The primary model used to
evaluate the function and plasticity of the inner hair cell ribbon synapse following noise
insults has been the mouse (Yuan, et al., 2014; Tong, et al., 2013; Brugeaud, et al., 2013).
We chose not to use the mouse for this model as the mouse is resistant to ototoxic
damage rendering it less suitable in the context of characterizing the mechanisms
associated with aminoglycoside ototoxicity (Taylor, et al., 2008). In illustration of this
point, i.e. studies using mice have induced mortality with high doses of aminoglycoside
without causing cochlear lesions (Murillo-Cuesta, et al., 2009).
In conclusion, this study confirms that aminoglycosides produce decreases in
inner hair cell ribbon densities without associated inner hair cell toxicity. The ribbon
density decreases detected in regions 16 and 17 suggest that there may an acute
neurotoxic effect of aminoglycoside exposure that could be targeted to produce enhanced
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protective therapies. Future studies should be conducted to establish the time course of
effects on inner hair cell ribbon densities and the impact on spiral ganglion viability.
Additionally, the connection between outer hair cell losses and ribbon density decreases
should be examined by inducing a more severe cochlear lesion.
References
Arpini A, Cornacchia L, Albiero L, Bamonte F, Parravicini L. 1979. Auditory function in
guinea pigs treated with netilmicin and other aminoglycoside antibiotics. Archives of
Oto- Rhino-Laryngology, 224(1-2):137-142.

Bae W, Kim L, Hur D, Jeong S, Kim J (2008) Secondary apoptosis of spiral ganglion
cells induced by aminoglycoside: Fas-Fas ligand signaling pathway. Laryngoscope,
118(9):1659-68.

Bielefeld E, Hangauer D, Henderson D (2011) Protection from impulse noise-induced
hearing loss with novel Src-protein tyrosine kinase inhibitors. Neurosci Res,. 71(4):34854.

Brown JJ, Brummett RE, Fox KE, Bendrick TW. 1980. Combined effects of noise and
kanamycin. Cochlear pathology and pharmacology. Archives of Oto- RhinoLaryngology, 106(12):744-50.

43

Brugeaud A, Tong M, Luo L, Edge A (2013) Inhibition of repulsive guidance molecule,
RGMa, increases afferent synapse formation with auditory hair cells. Dev Neurobiol.,
74(4):457-66.

Choung Y, Taura A, Pak K, Choi S, Masuda M, Ryan A (2009) Generation of highlyreactive oxygen species is closely related to hair cell damage in rat organ of Corti treated
with gentamicin. Neuroscience, 161(1):214-26.

Dallos P, Wang CY. 1974. Bioelectric correlates of kanamycin intoxication. Audiology,
13(4):277-89.

Erdem T, Ozturan O, Iraz M, Miman M, Olmez E (2005) Dose-dependent dual effect of
melatonin on ototoxicity induced by amikacin in adult rats. Eur Arch Otorhinolaryngol.
262(4):314-21.

Fetoni A, Eramo L, Rolesi R, Troiani D, Paludetti G (2012) Antioxidant treatment with
coenzyme Q-ter in prevention of gentamycin ototoxicity in an animal model. Acta
Otorhinolaryngol Ital. 32(2):103-10.

Gong X, Celsi G, Carlsson K, Norgren S (2012) Protective effects of N-acetylcysteine
amide (NACA) on gentamicin-induced apoptosis in LLC-PK1 cells. Ren Fail. 34(4):48794.
44

Hangfu M, Zhao J, Din D. 1992. The prophylactic effect of thyroxin on kanamycin
ototoxicity in guinea pigs. Hearing Research, 61(1-2):132-136.

Hawkins, J., Engstrom, H. 1964. Effect of Kanamycin on Cochlear Cytoarchitecture.
Acta Oto-laryngologica, 57, s188: 100-107.

Hiel H, Bennani H, Erre J, Aurousseau C, Aran J (1992) Kinetics of gentamicin in
cochlear hair cells after chronic treatment. Acta Otolaryngol. 112(2):272-7.

Imamura S, Adams J (2003) Distribution of gentamicin in the guinea pig inner ear after
local or systemic application. J Assoc Res Otolaryngol. 4(2):176-95.

Ishii T, Ishii D, Balogh K Jr. 1968. Lysosomal enzymes in the inner ears of kanamycintreated guinea pigs. Acta Oto-laryngologica, 65(5):449-458.

Kashio A, Sakamoto T, Kakigi A, Suzuki M, Suzukawa K, Kondo K, Sato Y, Asoh S,
Ohta S, Yamasoba T (2012) Topical application of the antiapoptotic TAT-FNK protein
prevents aminoglycoside-induced ototoxicity. Gene Ther. 19(12):1141-9.

Kujawa S, Liberman M (2009) Adding insult to injury: cochlear nerve degeneration after
"temporary" noise-induced hearing loss. J Neurosci. 29(45):14077-85.
45

Kujawa S, Liberman M (2006) Acceleration of age-related hearing loss by early noise
exposure: evidence of a misspent youth. J Neurosci., 26(7):2115-23.

Le Prell C, Ojano-Dirain C, Rudnick E, Nelson M, DeRemer S, Prieskorn D, Miller J
(2014) Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity. J
Assoc Res Otolaryngol., 15(3):375-93.

Li H, Steyger P (2011) Systemic aminoglycosides are trafficked via endolymph into
cochlear hair cells. Sci Rep,. 1:159.

Lin H, Furman A, Kujawa S, Liberman M (2011) Primary neural degeneration in the
Guinea pig cochlea after reversible noise-induced threshold shift. J Assoc Res
Otolaryngol., 12(5):605-16.

Maniu A, Perde-Schrepler M, Cosgarea M (2011) Protective effect of L-N-acetylcysteine
against gentamycin ototoxicity in the organ cultures of the rat cochlea. Rom J Morphol
Embryol., 52(1):159-64.

Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA. 1997.
Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss.
International Journal of Developmental Neuroscience, 15(4-5): 631-643.
46

Montalbano G, Abbate F, Levanti M, Germanà G, Laurà R, Ciriaco E, Vega J, Germanà
A (2014) Topographical and drug specific sensitivity of hair cells of the zebrafish larvae
to aminoglycoside-induced toxicity. Ann Anat., 196(4):236-40.

Murillo-Cuesta S, Contreras J, Cediel R, Varela-Nieto I. (2010). Comparison of different
aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice. Lab
Anim. 44(2):124-31.

Ojano-Dirain C, Antonelli P, Le Prell C (2014) Mitochondria-targeted antioxidant
MitoQ reduces gentamicin-induced ototoxicity. Otol Neurotol. 35(3):533-9.

Park S, Back S, Park K, Seo J, Noh H, Akil O, Lustig L, Yeo S (2013) Comparison of
functional and morphologic characteristics of mice models of noise-induced hearing loss.
Auris Nasus Larynx. 40(1):11-7.

Pavlidis P, Maurer J, Apostolidou E, Kekes G, Kouvelas D (2014) Memantine's action
against aminoglycoside-induced ototoxicity. Eur Arch Otorhinolaryngol. 271(6):1491-6.

Poirrier A, Van den Ackerveken P, Kim T, Vandenbosch R, Nguyen L, Lefebvre P,
Malgrange B (2010) Ototoxic drugs: difference in sensitivity between mice and guinea
pigs. Toxicol Lett. 193(1):41-9.
47

Safieddine S, El-Amraoui A, Petit C (2012) The auditory hair cell ribbon synapse: from
assembly to function. Annu Rev Neurosci. 35:509-28.

Schmitz H, Johnson S, Santi P (2014) Kanamycin-furosemide ototoxicity in the mouse
cochlea: a 3-dimensional analysis. Otolaryngol Head Neck Surg. 150(4):666-72.

Sha S, Taylor R, Forge A, Schacht J (2001) Differential vulnerability of basal and apical
hair cells is based on intrinsic susceptibility to free radicals. Hear Res. 155(1-2):1-8.

Shi L, An Y, Wang A, Gao Q, Yang Y (2014) The protective effect of Salvia miltiorrhiza
on gentamicin-induced ototoxicity. Am J Otolaryngol. 35(2):171-9.

Song BB, Sha SH, Schacht J. 1998. Iron chelators protect from aminoglycoside-induced
cochleo- and vestibulo-toxicity. Free Radical Biology and Medicine, 25(2):189-195.

Taylor RR, Nevill G, Forge A (2008) Rapid hair cell loss: a mouse model for cochlear
lesions. J Assoc Res Otolaryngol. 9(1):44-64.

Tong M, Brugeaud A, Edge A (2013) Regenerated synapses between postnatal hair cells
and auditory neurons. J Assoc Res Otolaryngol. 14(3):321-9.

48

Toyoda Y., and Tachibana M. 1978. Tissue Levels of Kanamycin in Correlation with
Oto- And Nephrotoxicity. Acta Oto-laryngologica, 86 (1-6): 9-14.

van Loon M, Ramekers D, Agterberg M, de Groot J, Grolman W, Klis S, Versnel H
(2013) Spiral ganglion cell morphology in guinea pigs after deafening and neurotrophic
treatment. Hear Res. 298:17-26.

Wang Y, Ren C (2012) Effects of repeated "benign" noise exposures in young CBA
mice: shedding light on age-related hearing loss. J Assoc Res Otolaryngol. 13(4):505-15.

Wang Q, Steyger P (2009) Trafficking of systemic fluorescent gentamicin into the
cochlea and hair cells. J Assoc Res Otolaryngol. 10(2):205-19.

Wang A, Sha S, Lesniak W, Schacht J (2003) Tanshinone (Salviae miltiorrhizae extract)
preparations attenuate aminoglycoside-induced free radical formation in vitro and
ototoxicity in vivo. Antimicrob Agents Chemother. 47(6):1836-41.

Wu W, Sha S, Schacht J (2002) Recent advances in understanding aminoglycoside
ototoxicity and its prevention. Audiol Neurootol. 7(3):171-4.

Yamane H, Nakai Y, Harada H, Minowa Y. 1983. Alteration of strial capillary transport
in kanamycin-treated guinea pigs. Archives of Oto- Rhino-Laryngology, 238(3):273-279.
49

Ye L, Tao Z, Hua Q, Xiao B, Zhou X, Li J, Yuan Y (2009) Protective effect of melatonin
against gentamicin ototoxicity. J Laryngol Otol. 123(6):598-602.

Yu Q, Chang Q, Liu X, Wang Y, Li H, Gong S, Ye K, Lin X (2013) Protection of spiral
ganglion neurons from degeneration using small-molecule TrkB receptor agonists. J
Neurosci. 33(32):13042-52.

Yuan Y, Shi F, Yin Y, Tong M, Lang H, Polley D, Liberman M, Edge A (2014) Ouabaininduced cochlear nerve degeneration: synaptic loss and plasticity in a mouse model of
auditory neuropathy. J Assoc Res Otolaryngol. 15(1):31-43.

50

CHAPTER III
EXPERIMENT 2: TIME COURSE EVALUATION OF INNER HAIR CELL
RIBBON DENSITIES FOLLOWING 10 DAYS OF KANAMYCIN EXPOSURE
Introduction
Previously, we revealed that kanamycin administration produced significant
decreases in presynaptic inner hair cell ribbons after seven days of administration. In this
experiment, inner hair cell ribbon densities decreased specifically in basal regions
associated with increased outer hair cell losses and minimal to no inner hair cell losses.
Lower doses of kanamycin were administered on study, but they did not produce changes
in ribbon densities or hair cell losses. This suggests that a level of hair cell toxicity must
be achieved to induce ribbon density changes.
Type I spiral ganglion neurons are connected to inner hair cells and represent ~95
percent of the neuronal population of the ganglion (Coate and Kelly, 2013). These
neurons are maintained by neurotrophins that are expressed from the inner hair cells and
cochlear supports cells (Despres et al., 1994, Medd and Bianchi, 2000, Zilberstein et al.,
2012). In models of aminoglycoside ototoxicity, auditory hair cell death occurs acutely
following treatment and secondary spiral ganglion degeneration occurs weeks to months
later (Jeong et al., 2010, Alam et al., 2007).
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Models of noise-induced synaptopathy demonstrate that once inner hair cell
ribbons are lost the spiral ganglion shows secondary degeneration months after the initial
insult (Kujawa and Liberman, 2009, Lin et al., 2011). In these models, the degree of
ribbon loss is highly correlated with the degree of spiral ganglion loss. These results
suggest that our aminoglycoside model of presynaptic ribbon loss may produce similar
spiral ganglion losses.
This study was conducted to determine if higher concentrations of kanamycin
produce greater magnitude decreases in ribbon densities and or produce additional areas
of damage/synaptic loss along the length of the cochlea (more apical regions).
Additionally, the time course of changes in ribbon densities and spiral ganglion densities
were assessed at multiple intervals following kanamycin administration. The results
indicate that higher concentrations of kanamycin induce ribbon changes in larger areas of
the cochlea with an associated greater magnitude of loss in each area. Interesting, the
results indicate that these changes are transient and recover over time. The initial
decreases in ribbon density produced no spiral ganglion degeneration at 56 days
following kanamycin administration.
Methods
Subjects
All animal use and the study protocol were approved by the Institutional Animal
Care and Use Committee at MPI Research Inc., a fully AALAC-accredited research
facility. Forty five male albino Hartley guinea pigs (Charles River laboratories, MI) were
placed on study at 6 weeks of age. The animals were single housed in wire mesh caging
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and provided environmental enrichments. All subjects were placed on ad libitum access
to both food and water and weighed between 250 and 400 g at the initiation of the
experiment. The room was temperature and humidity regulated with fluorescent lighting
provided on a 12 hour light/dark cycle (0600h – 1800h). Clinical observations were
conducted twice daily by AALAS-accredited research technicians that monitored food
and water access as well as the general health and wellbeing of the animals.
Study Design
Forty-five guinea pigs were placed into treatment groups of 5 animals per group.
The animals received subcutaneous (SC) injections of saline, or kanamycin at 200 or 400
mg/kg once daily for 10 consecutive days. Designated animals from each treated group
were euthanized at 1, 14, and 56 days following the final kanamycin dose. Kanamycin
sulfate (Sigma Aldrich, MO) was formulated as an 80 mg/ml solution in normal sterile
saline USP (0.9% sodium chloride). Normal sterile saline USP (Sigma Aldrich, MO) and
formulated kanamycin doses were administered subcutaneously at a volume equivalent of
5 ml/kg.
Auditory Brainstem Response (ABR) Evaluations
All animals underwent bilateral auditory brainstem response (ABR) evaluations at
4, 8, 10, 16, and 20 kHz prior to being assigned to study, and on the day prior to
euthanasia for each time interval. The sound presentation was generated using an RZ6
multi I/O processor (TDT Technologies, FL). The animals were anesthetized with an
intraperitoneal drug combination of 40 mg/kg ketamine hydrochloride (100 mg/ml) and
0.25 mg/kg of dexmedetomidine (0.50 mg/ml). Once a stable plane of anesthesia was
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confirmed as a lack of pain response, the animals were placed in the prone position
within an electrically shielded sound attenuation chamber. Pin lead electrodes were
placed to collect the ABR biopotential data. The lead configuration used to collect the
electrophysiological data consisted of a positive lead under the target ear, a reference lead
at the vertex of the skull, and a ground lead under the contralateral ear. The terminal
ends of the pin leads were connected to a Medusa preamplifier with a 20X gain and a 4channel headstage (TDT Technologies, FL). The stimulus used to elicit the ABR
waveform was a 15 ms pure tone pip with a 1 ms rise/fall time. The tone pips were
delivered at a rate of 10 cycles per second through a MF-1 transducer (TDT
Technologies, FL). The stimulus intensity was attenuated in 10 dB steps beginning at 80
dB SPL. The biopotential data were averaged across the 512 stimulus presentations for
each intensity level. An auditory threshold was established by determining the level of
activity that was 5 dB higher than the sound pressure level that induced no recognizable
elements comprising an ABR waveform.
Tissue Processing
The day following the final ABR evaluation, all animals were euthanized by
carbon dioxide inhalation. Whole body intracardiac perfusion was performed by the
application of 0.9% saline followed by 4% w/v paraformaldehyde. The left and right
temporal bones from each animal were harvested.
The right temporal bones were placed directly in 0.5% paraformaldehyde and
stored in refrigerated conditions (2 - 8°C) until further processing. A small hole was
made in the apex of the left cochleae and the oval window was perforated to facilitate
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intrascalar perfusion of 4% paraformaldehyde. The left cochleae were then stored in a
solution of 0.5% paraformaldehyde and placed in refrigerated conditions (2 - 8°C) until
further processing.
The left cochleae were dissected to reveal the organ of Corti. The organ of Corti
was then fluorescently stained to identify the auditory hair cells and inner hair cell
ribbons. For staining, the tissues were first placed in a blocking solution consisting of
1% goat serum (Invitrogen, CA) and 0.3% Triton X-100 in phosphate buffered saline
(PBS). The cochleae were then incubated overnight in a primary antibody solution of
1:100 mouse anti-CtBP2 antibody (BD Transduction Laboratories, CA). The cochleae
were rinsed and then incubated for an hour in a secondary antibody solution containing
1:200 Alexa Fluor® 488 Goat anti-mouse IgG (H+L) antibody (Life Technologies, CA)
and 1:200 Alexa Fluor® 568 phalloidin (Life Technologies, CA).
The right temporal bone from each animal was placed in a 10% EDTA and
decalcified in a tissue microwave (500W, 25ºC) for 14-21 days, or until appropriately
decalcified. Following decalcification, the temporal bones were dissected on a bias
placing the cochlea on a parallel plane with the microtomy blade. The cochlea was
mounted in paraffin and preliminarily sectioned until the mid modiolar region was
reached. Once located, five 5 µm sections were serially obtained from each cochlea and
then processed and stained using a standard haematoxylin and eosin staining procedure.
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Imaging and Analysis
All tissue imaging for the left organ of Corti was conducted using a Zeiss
Axiovert 200M confocal microscope at 63X magnification. Using a photo reticule, the
left organs of Corti were separated into 0.98 mm segments beginning in the apex and zstack images were captured for each segment. For image capture, z-stacks were created
using a 0.2 µm step size. The images were deconvolved and saved as individual planes.
Each plane per region was then imported into ImageJ v1.47t for 3D reconstruction. A 3D
project was created for each region allowing 90 degree rotation at the x-axis of the 3D
image. Using the cell counter plugin, the number of CtBP2 ribbons was manually
counted at the base of each inner hair cell. The present and missing outer and inner hair
cells were quantified within each of these regions to assess the severity of drug-induced
damage. The CtBP2 ribbon density per inner hair cell was then calculated for each
region.
The midmodiolar sections of the right cochlea were analyzed using Bioquant
Osteo II imaging software. The software was used to collect images from seven regions
of each cochlea (apical turn 2 (A2), mid turn 1 (M1), mid turn 2 (M2), and basal turn 1
(B1)) using a 20X objective. The software was then used to determine the area of each
region by outlining the Rosenthal’s canal. Within the outlined region, each Type I spiral
ganglia cell (corresponding to inner hair cell innervation) was counted using the criteria
that each cell will be myelinated (presence of a sheath) and will also possess a nucleolus.
Cell count and Rosenthal’s canal area were used to calculate spiral ganglion density.

56

Statistical Analyses
Hair cell counts and synapse densities were compared between groups using
descriptive statistics (mean ± SD). Each group’s hair cell counts were averaged into 0.98
sections. The CtBP2 ribbons/inner hair cell densities in each region and spiral ganglion
densities per cochlear turn were averaged for each group. All group comparisons were
conducted using an Analysis of Variance (ANOVA) procedure, followed by Tukey post
hoc tests. All statistical analyses were performed using Graphpad Prism v4.00.
Results
Auditory Brainstem Response Evaluations
At 1 day following the last day of kanamycin administration, there were no
notable changes in threshold at any of the frequencies assessed (4, 8, 10, 16, and 20 kHz)
in any dose group. After 14 days from the last day of kanamycin dosing, the average
threshold for each frequency in the 400 mg/kg kanamycin dose group significantly
increased to 71 ± 15.30 dB SPL at 4 kHz (p≤0.05), 56 ± 16.43 dB SPL at 8 kHz (p≤0.05),
68 ± 18.18 dB SPL at 10 kHz (p≤0.01), 54 ± 21.12 dB SPL at 16 kHz (p≤0.001), and 69
± 15.42 dB SPL at 20 kHz (p≤0.001). There were no significant threshold differences
detected between the 200 mg/kg dose group and controls at this time. The thresholds in
the 400 mg/kg dose group continued to increase at day 56 presenting with averages of 79
± 21.14 dB SPL at 4 kHz (p≤0.001), 70 ± 22.03 dB SPL at 8 kHz (p≤0.001), 78 ± 21.79
dB SPL at 10 kHz (p≤0.001), 70 ± 18.41 dB SPL at 16 kHz (p≤0.001), and 79 ± 10.48 dB
SPL at 20 kHz (p≤0.001).

Again, there were no significant threshold increases noted in
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the 200 mg/kg dose group at this time. The ABR data from each time interval is
displayed in Figures 4, 5, and 6.
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Figure 4. ABR threshold 1 day following kanamycin administration.
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Figure 5. ABR threshold 14 days following kanamycin administration.
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Figure 6. ABR threshold 56 days following kanamycin administration.
Auditory Hair Cell Analysis
The hair cell analyses for each dose group are presented in Figures 7, 8, and 9.
The missing outer and inner auditory hair cells were averaged into 0.98 mm segments
beginning in the apex of the cochlea, and are presented as successive regions. As shown
in Figure 7, there were moderate increases in outer hair cell losses observed below region
18 and minor increases in inner hair cells below region 20 in the 400 mg/kg dose group.
There were no other hair cell losses observed in the other dose groups at this time. At 14
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days following the last dose, outer hair cell losses above 50% or more were noted in all
regions beginning in region 11 through region 21 in the 400 mg/kg dose group. Again,
there were only minor increases in inner hair cell losses noted in region 20. Interestingly,
there was a large spike in outer hair cell losses observed in the 200 mg/kg dose group at
region 21. The hair cell analysis from 56 days following the last dose presented with
similar losses as those observed 14 days following the last kanamycin dose. The 400
mg/kg dose group had losses above 50% beginning in region 11 and ending at region 21.
There were no other prominent losses in the other dose groups at this time interval.
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Figure 7. % missing hair cells 1 day following kanamycin administration.

62

22

Day 14 After the Last Kanamycin Dose
% Missing Hair Cells

100

IHC Saline
OHC Saline
IHC 200 mg/kg Kanamycin
OHC 200 mg/kg Kanamycin
IHC 400 mg/kg Kanamycin
OHC 400 mg/kg Kanamycin

90
80
70
60
50
40
30
20
10
0
2

4

6

8

10

12

14

16

18

20

Cochlear Region
(0.98 mm Segments from Apex)

Figure 8. % missing hair cells 14 days following kanamycin administration.
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Figure 9. % missing hair cells 56 days following kanamycin administration.

Inner Hair Cell Ribbon Density
The inner hair cell ribbon densities were determined in cochlear regions 16-21
(exactly 15.68, 16.66, 17.64, 18.24, 19.6, and 20.58 mm from apex, respectively). There
was a significant decrease in ribbon density identified in region 19 of the 200 mg/kg dose
group 1 day following the last dose (p≤0.05). Similarly, there were also significant
decreases detected in regions 19 and 20 of the 400 mg/kg dose group at this time
(p≤0.05). Interestingly, the ribbon densities recovered to control levels by 14 days
following the last dose in both dose groups. This recovery was not maintained when
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assessed 56 days from the last kanamycin dose, as significant ribbon density decreases
were again identified in region 18 of the 400 mg/kg dose group. All inner hair cell ribbon
density data are presented in Figures 10, 11, and 12.
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Figure 10. (10A) Inner hair cell ribbon density 1 day following kanamycin
administration; (10B) image of control ribbon synapses; (10C) image of treated ribbon
synapses.
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Figure 11. (11A) Inner hair cell ribbon density 14 days following kanamycin
administration; (11B) image of control ribbon synapses; (11C) image of treated ribbon
synapses.

67

Day 56 After the Last Dose
Ribbon Synapse Density (Ribbons/Inner Hair Cell)
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Figure 12. (12A) Inner hair cell ribbon density 56 days following kanamycin
administration; (12B) image of control ribbon synapses; (12C) image of treated ribbon
synapses.
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Type I Spiral Ganglion Density Evaluations
The average Type I spiral ganglia density for each cochlear turn evaluated in the
400 mg/kg kanamycin dose group is presented in table 2. Given that the ribbon density
changes were isolated to the furthest basal regions of the cochlea in the left ears, the data
generated from the basal turn of the midmodiolar sections from the right ears were clearly
most relevant in terms of further characterizing kanamycin neurotoxicity. The Type 1
spiral ganglia density results showed that there were no differences in the average density
measurements between any of the intervals assessed in the 400 mg/kg dose group.

B1
M1

A2

M2

1mm

Figure 13. Example midmodiolar section with labeled cochlear turns.
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Table 2
Type I Spiral Ganglia Density Measurements from Mid-Modiolar Sections of the
Basal Cochlea by Interval
Cochlear Turn (cells/mm2)
M1
M2

Interval
1 Day Following the Last
400 mg/kg Kanamycin Dose

A2

B1

1.54 ± 0.21

1.3 ± 0.21

1.5 ± 0.16

1.21 ± 0.21

14 Days Following the Last
400 mg/kg Kanamycin Dose

1.4 ± 0.3

1.59 ± 0.16

1.62 ± 0.17

1.26 ± 0.35

56 Days Following the Last
400 mg/kg Kanamycin Dose

1.63 ± 0.14

1.51 ± 0.15

1.53 ± 0.18

1.4 ± 0.26

Discussion
This study demonstrates that ten consecutive days of kanamycin administration
produces profound outer hair cell losses with minimal cytotoxic effects on inner hair
cells. The present results also indicate that presynaptic inner hair cell ribbons decrease
initially following kanamycin administration, but then regenerate over time. There
appears to be no corresponding effect on spiral ganglion cellular density over time which
implies that ribbons may regenerate, restoring functional support to the type I neurons.
In this study, the number of kanamycin doses was increased from 7 to 10. This
experimental design modification was made in order to produce greater hair cell toxicity,
and also examine effects on inner hair cell ribbon densities. The increased number of
doses produced severe outer hair cell loss through the mid and basal turns of the organ of
Corti. Interestingly, this increased hair cell death, which is associated with exposure to
high concentrations of drug, was accompanied by greater decreases in ribbon densities
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and also affected a greater length of the cochlear partition. These results suggest that in
addition to OHC cytotoxicity, this regimen of drug exposure directly impacts the severity
of the ribbon loss observed.
Recently, Lin et al. (2011) suggested that the use of ribbon markers alone to
quantify synapse activity is insufficient, as cochlear insults can produce ribbons that do
not display the normal association with the inner hair cell active zone and/or plasma
membrane. These same ribbon anchorage issues have been observed in in-vitro models
of glutamate toxicity (Wang and Green, 2011). The displaced ribbons do not have a
postsynaptic connection and lead to underestimates of the number of lost synapses. For
this reason, it has been suggested that synapse density values can only be accurately
measured using dual markers of pre- and post-synaptic proteins. Future studies should
examine the effect of aminoglycosides on inner hair cell - auditory neuron connections to
determine if functional synapses are formed during the recovery observed in this study.
Although we only used a presynaptic marker to monitor inner hair cell synapse
densities, these results suggest, that unlike noise-induced synaptopathy, aminoglycosides
may produce a transient decrease in ribbon densities followed by a subsequent recovery
in numbers. This in-vivo finding is rare in terms of synapse recovery as the only other
demonstration of a recoverable synaptopathic injury has been induced by AMPA/kainite
administration (Pujol and Puel, 1999). Direct inferences cannot be drawn between these
models, however as the administration of AMPA/kainite acts directly on afferent
neuronal glutamate receptors and not the presynaptic ribbons (Puel et al., 1995, Puel et
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al., 1997). Nevertheless, the AMPA/kainite models provide support that in-vivo inner
hair cell synapse re-innervation is possible.
In the noise-induced synaptopathy models, the loss of inner hair cell ribbons and
postsynaptic connections lead to delayed spiral ganglion degeneration (Kujawa and
Liberman, 2009, Kujawa and Liberman, 2006). The inner hair cells are largely
unaffected in these experiments, which suggest that inner hair cell synaptic activity is
critical to maintain spiral ganglion cell survival (Sergeyenko et al., 2013; Stamataki et al.,
2006). The lack of secondary degeneration in the spiral ganglion in our study supports
the possibility that functional connections were formed after expression of the initial
insult.
The spiral ganglion begins to degenerate in the guinea pigs following
aminoglycoside treatment only weeks after the initial insult, but continues to decline
through approximately 12 months (Yamagata et al., 2004, Duan et al., 2000). Generally,
aminoglycosides produce a lesion characterized by outer hair cell loss in the basal region
of the cochlea which progresses apically, followed thereafter by inner hair cell death
(Fee, 1980). The observed delay in inner hair cell loss may explain the time course of
spiral ganglion degeneration, given the supportive role of inner hair cells in maintaining
neuronal viability. In models of hair cell ablation, where both inner and outer hair cell
death is rapidly induced by aminoglycosides and loop diuretics, spiral ganglion neurons
begin to degenerate at an increased rate beginning as early as several weeks after loss of
outer and inner hair cells (Agterberg et al., 2009, Tan and Shepherd, 2006, McFadden et
al., 2004). Our study examined spiral ganglion densities out to 56 days following the
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cochlear injury, showing no effects. However, longer term examinations should be
conducted to assess continued term survival of these neurons and synaptic connections.
In conclusion, our results suggest that aminoglycosides produce significant inner
hair cell ribbon loss in basal regions of the cochlea followed by a recovery of the ribbons.
This implies that aminoglycosides produce a coverable synaptopathy. Future studies
should be conducted to assess both the pre- and post-synaptic effects of aminoglycosides
on inner hair cell – auditory neuron connections.
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CHAPTER IV
EXPERIMENT 3: TIME COURSE CHARACTERIZATION OF THE
EFFECTS OF KANAMYCIN ON AUDITORY HAIR CELL
SYNAPSE PLASTICITY

Introduction
Synaptopathy following noise and other insults to the cochlea has been shown to
alter auditory temporal precision and suprathreshold waveform magnitude (Moser et al.,
2006). There are several types of potential synaptopathic insults in the cochlea and there
appears to be a variable response of the inner hair cell to re-innervate following each
type. Understanding the recoverability of synaptopathy following the different insults
could provide insights into potential therapeutic interventions to recover auditory
sensitivity.
Our laboratory has observed that ototoxic doses of kanamycin produce a transient
decrease in inner hair cell ribbon density followed by recovery over time. The inner hair
cells are spared during the ototoxic treatment, but severe outer hair cell losses are
observed through the mid and basal turns of the cochlea. Though no postsynaptic
markers were used in this experiment, the regenerated ribbons appeared to regain
synaptic function as no spiral ganglion degeneration was observed 56 days following the
last dose of kanamycin. Chen et al (2012) found similar inner hair cell synaptic loss in
mice following gentamicin exposure. Although Chen et al. did not conduct quantitative
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synapse measures months after the insult, no synaptic recovery was observed
weeks after gentamicin administration. If the postsynaptic afferent connections do in fact
re-innervate regenerated ribbons, these results would be contrary to what has been found
in noise induced models of synaptopathy.
Kujawa and Liberman (2006, 2009) showed that a mild noise exposure, yielding a
temporary threshold shift, could be followed by complete recovery of auditory
sensitivity, but inner hair cell synapses were permanently reduced. The observed
reduction of synapse number leads to a secondary degeneration of type-I spiral ganglion
neurons (Sergeyenko et al., 2013; Stamataki et al., 2006). It has been suggested that
moderate noise exposures preferentially affect high threshold, low spontaneous rate
afferent fibers, which may contribute to reduced speech discrimination late in life where
concomitant hair cell loss is not observed (Furman et al., 2013). This may be a speciesspecific anomaly, as other studies have shown that noise-induced synaptopathy in guinea
pigs is recoverable, and does not show spiral ganglion degeneration months after the
insult (Shi et al., 2013, Liu et al. 2012).
Synaptic regeneration has been shown to occur following in-vivo cochlear
perfusions of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and/or
kainic acid with complete recovery of auditory function (d’Aldin et al, 1997; Pujol et al.,
1999; Puel et al. 1994). This re-innervation has also been confirmed in in-vitro models of
excitotoxicity. Wang and Green (2011) showed that direct administration of NMDA and
kainic acid to organ of Corti explants resulted in a 99% reduction in inner hair cell
synapses. Kainic acid administration caused presynaptic ribbon migration to perinuclear
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locations within the inner hair cell, with postsynaptic terminal regeneration over time.
These inner hair cell synapses regenerated following kainic acid exposure, but the
recovery was quantitatively incomplete.
Building from our prior results showing inner hair cell ribbon regeneration, the
current study was conducted to determine if both the pre- and post-synaptic elements of
the inner hair cell synapse regenerate following administration of ototoxic doses of
kanamycin. The use of co-localized pre- and post-synaptic markers to assess synaptic
integrity provides a more precise evaluation of pathophysiology as cochlear insults
appear to produce orphan ribbons which lack a postsynaptic connection (Yuan and Chi,
2014; Tong et al., 2013; Liberman et al., 2012; Lin et al., 2011). The current study
therefore used co-appearance of CTBP2 (presynaptic ribbons) and GlurR2/3 (abundant
afferent postsynaptic glutamate receptors) as markers for the inner hair cell synapses.
The inner hair cell synapses were assessed in the basal regions of the cochlea at 17.6 and
18.6 mm from the apex, located in the 32 kHz frequency region (Viberg and Canlon,
2004).
The results supported the hypothesis that aminoglycoside treatment can induce
loss of inner hair cell - auditory nerve synapses, and also that synaptic reconnection
occurs in this model. Inner hair cell synapses significantly decreased 1 day following the
last of 10 daily doses of kanamycin, with significant increases in both pre- and postsynaptic components observed 14 and 58 days following treatment termination.
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Methods
Subjects
All animal use was approved by the Institutional Animal Care and Use Committee
at MPI Research Inc., a fully AALAC-accredited research facility. Forty eight male
albino Hartley guinea pigs (Charles River laboratories, MI) were placed on study at 8
weeks of age. The animals were single housed in plastic shoe box caging with sanitized
wood chips and environmental enrichments. All subjects were placed on ad libitum
access to both food and water and weighed between 250 and 500 g at the initiation of the
experiment. The room was temperature and humidity regulated with fluorescent lighting
provided on a 12 hour light/dark cycle (0600h – 1800h).
Study Design
Forty-eight guinea pigs were randomly placed into six treatment groups of 8
animals per group. Three treatment groups received a subcutaneous dose of saline, and
the remaining 3 treatment groups received a subcutaneous dose of 400 mg/kg kanamycin
sulfate. All groups received one dose daily for ten consecutive days. Kanamycin sulfate
(Sigma Aldrich, MO) was formulated as an 80 mg/ml solution in normal sterile saline
USP (0.9% sodium chloride). Normal sterile saline USP (Sigma Aldrich, MO) and
formulated kanamycin doses were administered subcutaneously at a volume equivalent of
5 ml/kg. One kanamycin and one saline treated group were euthanized at one of three
time intervals (1, 14, or 58 days following the termination of dosing).
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Auditory Brainstem Response (ABR) Evaluations
Unilateral (left ear) ABR evaluations were conducted at 32 kHz prior to study
initiation and prior to the designated terminal time interval. The sound presentation was
generated using an RZ6 multi I/O processor (TDT Technologies, FL). The animals were
anesthetized with an intraperitoneal drug combination of 40 mg/kg ketamine
hydrochloride (100 mg/ml) and 0.25 mg/kg of dexmedetomidine (0.5 mg/ml). Once a
stable plane of anesthesia was confirmed as a lack of pain response, the animals were
placed in the prone position within an electrically shielded sound attenuation chamber.
Pin lead electrodes were placed to collect the ABR biopotential data. The lead
configuration used to collect the electrophysiological data consisted of a positive lead
under the target ear, a reference lead at the vertex of the skull, and a ground lead under
the contralateral ear. The terminal ends of the pin leads were connected to a Medusa
preamplifier with a 20X gain and a 4-channel headstage (TDT Technologies, FL). The
stimulus used to elicit the ABR waveform was a 5 ms pure tone pip with a 0.5 ms rise/fall
time. The 32 kHz tone was delivered in a closed-field at a rate of 10.1 cycles per second
through a MF-1 transducer (TDT Technologies, FL). The stimulus intensity was
attenuated in 10 dB steps beginning at 80 dB SPL. The biopotential data were averaged
across the 512 stimulus presentations for each intensity level. An auditory threshold was
established by determining the level of activity that was 5 dB higher than the sound
pressure level that induced no recognizable elements comprising an ABR waveform.
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Tissue Processing
Animals were euthanized via carbon dioxide inhalation on the day following the
final ABR evaluation. Whole body intracardiac perfusion of 0.9% saline followed by 4%
w/v paraformaldehyde was conducted. The left temporal bone from each animal was
harvested and intrascalar perfusion using 4% paraformaldehyde was carried out through a
small hole in the apex of each cochlea and the oval window. The cochleae were then
stored overnight in a solution of 0.5% paraformaldehyde at 2 - 8°C.
The otic capsule and overlying tissues were removed to reveal the organ of Corti.
To label the presynaptic ribbons (CtBP2), postsynaptic glutamate receptors (GluR2/3),
and the auditory hair cells (Phalloidin), the organs of Corti were first placed in a blocking
solution consisting of 1% goat serum (Invitrogen, CA) and 0.3% Triton X-100 in
phosphate buffered saline (PBS) with calcium and magnesium. This was followed by coimmunolabeling with a primary antibody solution comprised of 1:100 mouse anti-CtBP2
antibody (BD Transduction Laboratories, CA) and 1:100 rabbit anti-GluR2/3 polyclonal
antibody (Millipore, MA) overnight at 2 - 8°C. Cochleae were then rinsed in phosphate
buffered saline (PBS) with calcium and magnesium, and then incubated for an hour in a
secondary antibody solution containing 1:200 Alexa Fluor® 488 Goat anti-mouse IgG
(H+L) antibody (Life Technologies, CA), 1:200 Alexa Fluor® 568 goat anti-rabbit IgG
(H+L) antibody (Life Technologies, CA), and 1:200 Alexa Fluor® 350 phalloidin (Life
Technologies, CA).
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Imaging and Analysis
The organ of Corti was microdissected in four surface preparations and viewed
using a Zeiss Axiovert 200M confocal microscope at 63X magnification. The surface
preparations were viewed in 0.98 mm segments beginning in the apex for the purposes of
locational analysis using a photo reticule. The regions corresponding to 17.6 and 18.6
mm from apex were selected for confocal imaging. For image capture, z-stacks were
created using a 0.4 µm step size. The images were deconvolved and saved as individual
planes. Each plane per region was then imported into ImageJ v1.47t for 3D
reconstruction. A 3D project was created for each region allowing 90 degree rotation at
the x-axis of the 3D image. Using the cell counter plugin, the number of closely apposed
or co-localized CtBP2 and GluR2/3 puncta were manually counted at the base of each
inner hair cell in the region of interest using a digital zoom of 400X, and the mean
synapse density per inner hair cell calculated for that region. The mean for each
treatment group was determined, and inner hair cell synapse density averages were
analyzed for significant differences between the 1, 14, and 58 day intervals. The number
of present and missing outer and inner hair cells within the reticule length for each region
was also determined.
Statistical Analyses
The ABR data, missing hair cell data, and inner hair cell synapse density
measures are presented as the mean ± 1 S.D. The ABR data and inner hair cell synapse
density averages were analyzed for significant differences between the 1, 14, and 58 days
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following treatment termination using one-way analysis of variance with Tukey post hoc
tests in Graphpad Prism v4.00.
Results
Auditory Brainstem Response Evaluations
The average pretest and terminal ABR threshold for each interval is shown in
Figure 14 as mean ± S.D. The average 32 kHz auditory threshold in the saline treated
group 1 day following treatment termination was 23.00 ± 5.88 dB SPL. The average
threshold of the kanamycin treated group at this time interval was significantly increased
to 47.88 ± 27.19 (p≤0.05). By 14 days from treatment termination, the average ABR
threshold continued to significantly increase to 72.50 ± 12.43 (p≤0.01) in the kanamycin–
treated group. The saline control group at this time point remained at baseline, with a
value of 21.38 ± 8.60. The ABR threshold increase plateaued and maintained at an
average of 73.50 ± 12.32 (p≤0.001) through Day 58 following treatment termination.
Again, the saline control group at this interval remained at a baseline level of 24.13 ±
8.79. These time course data indicate that 1 day following the termination of dosing the
cochlea is undergoing a process of dysfunctional changes that peak 14 days from
treatment termination, which is then maintained as reflected by the average Day 58 ABR
threshold.
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Figure 14. Time course effects of kanamycin on ABR threshold.

Hair Cell Analysis
The 10-day dose regimen of 400 mg/kg kanamycin produced robust outer hair cell
losses while largely sparing inner hair cells. The hair cell data evaluated within each
region are presented in Figures 15 and 16. At 1 day following treatment termination,
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there were no missing inner or outer hair cells in the 17.6 and 18.6 mm from apex regions
of the saline control group. The kanamycin-treated group at this time interval presented
with 50% missing outer hair cells within both the 17.6 and 18.6 mm from apex regions.
The kanamycin treated inner hair cells at this time interval incurred either no, or minimal
losses of 0 and 11% in the 17.6 and 18.6 mm from apex regions, respectively. At 14 days
subsequent to treatment termination, there were minor outer hair cell and no inner hair
cell losses observed in the saline control group. In contrast, there were outer hair cell
losses of 86% observed within each region evaluated in the kanamycin-treated group at
this interval. The inner hair cell losses characterized at this time were again either absent,
or minimal at 0 and 4% 17.64 and 18.6 mm from apex regions, respectively. The severity
of damage increased at 58 days in the kanamycin-treated group with 100% outer hair cell
losses in both regions. The inner hair cell sparing was still present at this time with 1%
losses observed in both regions assessed. Again, the saline control group 58 days
following treatment termination presented with minimal outer, and no inner, hair cell
losses within the 17.6 and 18.6 mm from apex regions.
Inner Hair Cell Synapse Density
Figures 15 and 16 show the inner hair cell synapse density changes for each time
interval assessed. At 1 day after treatment termination, there was a significant ~50%
reduction in synapse density observed in the 17.6 mm from apex region in the
kanamycin-treated group as compared to the time-matched saline control (p≤0.001). The
18.6 mm from apex region in the kanamycin-treated group presented with an even greater
~65% reduction in synapse density compared to the saline control at this same time
86

interval (p≤0.001). By 14 days from treatment termination, the kanamycin-induced
synapse degeneration had recovered to 33 and 48% percent of the saline control values in
the 17.6 mm and 18.6 mm from apex regions, respectively (both p≤0.001). This recovery
effect continued through 58 days, with the kanamycin-treated group average density
measures reaching minimal differences of only 17% relative to the control group at 17.6
mm from apex and 37% relative to the control group in the 18.6 mm from apex region
(p≤0.001). In the region of interest 17.6 mm from apex, the number of labeled
connections in the kanamycin treated group was no longer significantly reduced from the
saline controls at 56 days following cessation of treatment.
Many of the CTBP2 immunostained ribbons 14 days following kanamycin
treatment were qualitatively noted to be larger than those in the time matched control
group, similar to what has been reported days following noise overstimulation (Lin et al.,
2011; Kujawa and Liberman, 2009). Interestingly this was less evident in the 1 day and
58 day termination post treatment groups.
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Figure 15. (15A) Average inner hair cell synapse density at 17.64 mm from apex by
time interval; (15B) % missing hair cell loss at 17.64 mm from apex by time interval.
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Figure 16. (16A) Average inner hair cell synapse density at 18.62 mm from apex by
time interval; (16B) % missing hair cell loss at 18.62 mm from apex by time interval. 1
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17A
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17F
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5A
Figure 17. Representative 63X projection images of ribbon synapses from (17A) 1 day
control, (17B) 14 day control, (17C) 56 day control, (17D) 1 day treated, (17E) 14 day
treated, and (17F) 56 day treated tissues.
Discussion
This study confirms previous results indicating that inner hair cell ribbons
degenerate acutely and subsequently regenerate over time. The results of this study
demonstrate that the regenerated inner hair cell ribbons form connections with
postsynaptic afferent terminals. The magnitude of re-innervation observed in this study
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is comparable to what has been reported with kainic acid and AMPA insult both in vivo
(d'Aldin et al., 1997; Puel et al., 1995) and in vitro (Wang and Green, 2011). Boths
models of synaptic re-innervation are similar to the effects observed in guinea pigs after
noise exposure, but are in contrast to what has been reported following noise exposure in
mice, where synaptic connections are lost permanently (Kujawa and Liberman, 2009; Lin
et al., 2011). There may be a variety of pathologic and genetic factor contributing to
species differences in re-innervation phenomena. Obviously these differences in repair
plasticity raise the important issue of which model, if either, represent the human
condition.
Studies have shown that the neurotrophic factor NT-3 can play an important role
in regulation of the synaptic connections during postnatal development (Wan et al., 2013;
Sugawara et al., 2007) and regeneration following cochlear insults (Wang and Green,
2011). It has been shown that inner hair cells (Green et al., 2012) and supporting cells
(Sugawara et al., 2007; Stankovic et al., 2004) secrete this neurotrophic factor, which
helps maintain neuronal viability. Supporting cells have been shown to play a critical
role in maintaining spiral ganglion health by also secreting other neurotrophic and
protective factors (Sobkowicz et al., 2002, Stankovic et al., 2004, May et al. 2013,
Monzack and Cunningham, 2013). Given their role in fostering synaptic regeneration,
the key difference in re-innervation potential between noise exposure in mice and the
other models may be the severity of damage induced to the inner hair cell supporting cell
complex. Cochlear insults have been shown to cause damage in the form of free radical
formation in supporting cells (Ladrech et al., 2013, Inai et al., 2012; Du et al., 2011), but
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the insult may differentially affect supporting cell functions in each species, specifically
the expression of growth and other regulatory and protective factors during the acute
period following damage.
Our results illustrated greater regeneration and reconnection in the more apical of
the two regions of interest assessed. This supports an NT-3 contribution to the observed
re-innervation, as previous studies showed that NT-3 expression is greater apically in the
cochlea, and that regeneration after auditory nerve sectioning is greater in the apex
(Sugawara et al., 2005, 2007). At 14 days following the termination of kanamycin
dosing, we observed many inner hair cell ribbons that were qualitatively larger in size as
compared to the saline controls (see figure 18). This observation was not present at 58
days from the last dose. These same ribbon size changes have also been observed in the
noise-induced models of synaptopathy, although the change was permanent in these noise
models (Kujawa and Liberman et al., 2009).
This observation may provide insights into the processes involved in reinnervation. Sobkowicz et al. (1986) found an increase in the formation of presynaptic
complexes, accumulations of electron-dense vesicles at the presynaptic membrane
opposed to afferent nerve fibers, in denervated organ of Corti explants. In a process
described as reactive synaptogenesis, denervated cultures exhibit dendritic filapodia that
interact with the postsynaptic plasma membrane of inner hair cells (Sobkowicz et al.,
1998). Within 24 hours, inner hair cell ribbons preferentially migrate to these filapodia
forming large groupings of ribbons. Over time, the filapodia deteriorate and the large
ribbon groupings are no longer present, only leaving behind sparse inner hair cell
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synapses. The large ribbons observed at day 14 after dosing may represent a stage of
reactive synaptogenesis where large groupings of ribbons associate around neuronal
filapodia.

18A

18B

18C

Figure 18. Representative 63X projection images (x-z axis) from a (18A) day 14 control
inner hair cell, (18B) day 14 treated inner hair cell, and (18C) day 58 treated inner hair
cell from the 17.64 mm from apex.

There have been two recent studies that also examined the effects of
aminoglycoside administration on inner hair cell – auditory nerve synapses. Chen et al.
(2012) showed a pattern of declining numbers of inner hair cell – auditory nerve synapses
in the cochlea of mice using three alternating days of gentamicin administration. Inner
hair cell synapse densities were assessed on each dose day and indeed decreased with
each successive dose. This is consistent with our results where a large decrease was seen
one day subsequent to the 10th day of dosing. Chen et al (2012) did not look at later
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periods so there was no opportunity to see the re-innervation that we observed. Liu et al.
(2013) employed a 14-day dose regimen of gentamicin in mice, and contrary to our
results and those of Chen et al, (2012) found that inner hair cell synapse densities
increased over control levels during the dosing period, peaking on the 7th dose and then
returning to control levels by the 14th dose. We did not assess inner hair cell – auditory
neuron synapse densities during the dosing period, however the decrease we found 1 day
after cessation would suggest quite different effects in our model. It is possible that there
are species differences, as mice have been shown to be relatively resistant to
aminoglycoside ototoxicity (Poirrier et al., 2010; Blakley et al., 2008; Taylor, et al.,
2008). However, Chen et al (2012) also used the mouse model, and reported similar
decreases to present findings in guinea pig.
In conclusion, our data show that kanamycin administration produces inner hair
cell synapse degeneration with subsequent regeneration. These findings may provide a
platform for the understanding of synaptogenesis in the adult cochlea. In addition. this
model also may provide insights into developing treatments aimed at reducing
synaptopathy in patients with hearing loss.
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CHAPTER V
EXPERIMENT 4: ACUTE CHARACTERIZATION OF INTRAAURAL GENTAMICIN ON INNER HAIR CELL SYNAPSE
PLASTICITY
Introduction
Gentamicin is an aminoglycoside antibiotic historically used for the treatment of
gram negative bacterial infections (Mingeot-Leclercq, et al., 1999). Much like
kanamycin, gentamicin is oto- and nephrotoxic (Rybak and Ramkumar, 2007). Within
the class of aminoglycoside antibiotics, each compound appears to induce varying levels
of ototoxicity (Kotecha and Richardson, 1994). Despite this undesirable toxicity,
gentamicin is now commonly used as a secondary treatment for multi-drug resistant
tuberculosis and also in cases of severe infection (ATS-CDC, 1993).
Beyond systemic use as an antibacterial agent, gentamicin has been used for many
years as a treatment for Meniere’s disease (Silverstein et al., 2010, Bodmer et al., 2007).
The treatment of Meniere’s disease requires that gentamicin is injected through the
tympanum into the middle ear (Silverstein et al., 1999). The ototoxic properties of
gentamicin are exploited to ablate vestibular hair cells which in turn cause a reduction in
the vestibular dysfunction observed in this disease (Assimakopoulos and Patrikakos,
2003).
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During systemic administration of aminoglycosides, the drug distributes to the
inner ear, but peak concentrations are variable due to metabolism and clearance from the
systemic circulation (Tran Ba Huy, et al., 1986; Brummett, et al., 1978). Direct
administration of these types of drugs to the round window allows for a more controlled
delivery to the inner ear. One side-effect of transtympanic injections of gentamicin for
Meniere’s disease is high frequency hearing loss (Möller et al., 1988, Wu and Minor,
2003).
We recently showed that systemic administration of aminoglycoside antibiotics
produces significant synaptopathy in the basal regions of the cochlea at 17.6 and 18.6 mm
from apex following treatment. Our previous results also suggested there is a dosedependence in the inner hair cell ribbon loss observed. As both of these prior studies
were systemic administrations of kanamycin, this brings into question how other types of
aminoglycosides may affect inner hair cell synapse densities acutely, and also if doses of
intra-aural aminoglycosides will produce more dramatic changes in synapse densities
throughout the cochlea.
The current study was conducted to address both of these questions to develop a
better understanding of aminoglycoside antibiotics mechanisms of ototoxicity and
potential for regenerative processes. Gentamicin was selected for evaluation as it is
commonly used intra-aurally and systemically in clinical practice. Additionally, the test
subjects were surgically implanted with bilateral middle ear catheters to reduce systemic
distribution and to achieve high drug perilymph concentrations by direct round window
102

delivery. Our results show that gentamicin produces acute inner hair cell synapse density
reductions following administration similar to kanamycin. Furthermore, direct
administration of gentamicin to the middle ear produced profound inner hair cell synapse
loss beginning at 15.7 mm from apex of the cochlea without an associated inner hair cell
loss.
Methods
Subjects
All animal use and the study protocol were approved by the Institutional Animal
Care and Use Committee at MPI Research Inc., a fully AALAC-accredited research
facility. Five female albino Hartley guinea pigs (Charles River laboratories, MI) were
placed on study at 8 weeks of age. The animals were single housed, in plastic shoe box
caging with sanitized wood chips and environmental enrichments. All subjects were
placed on ad libitum access to both food and water and weighed between 250 and 500 g
at the initiation of the experiment. The room was temperature and humidity regulated
with fluorescent lighting provided on a 12 hour light/dark cycle (0600h – 1800h).
Clinical observations were conducted twice daily by AALAS-accredited research
technicians that monitored food and water access as well as the general health and
wellbeing of the animals.
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Drug Formulations
A 50 µl dose of a 200 mg/ml solution of gentamicin sulfate (Sigma Aldrich, MO)
formulated in normal sterile saline USP (0.9% sodium chloride) was administered
through a catheter into the right middle ear cavity of each animal. As a control, 50 µl of
normal sterile saline USP (Sigma Aldrich, MO) was also administered through an
additional catheter into the left middle ear of each animal.
Surgical Approach
All animals were instrumented with bilateral middle ear catheters using standard
sterile surgical procedures to facilitate direct administration of gentamicin. To place the
catheters, the animals were anesthetized with intraperitoneal dexmedetomidine (0.5
mg/kg; 0.5 mg/ml) and xylazine (10 mg/kg; 100 mg/ml, MWI Veterinary Supply, ID). A
midline skin incision was made on the dorsum of the head from approximately the medial
canthus caudally and then continuing post-auricularly to the base of each ear. Several
stainless steel screws were placed in the skull to anchor and stabilize each catheter. A
small hole was drilled slightly lower than the midpoint of the bulla of each ear, and a 22
gauge sterile catheter with an attachable injection port was inserted. The catheters were
secured within the hole with Carboxylate cement (Henry Schein Animal Health, OH).
The catheters were then further secured to the skull screws with fine gauge surgical steel
wire. Methyl methacrylate (Henry Schein Animal Health, OH) was then used to encase
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the catheters and skull screws. The animals were allowed 7 to 10 days recovery prior to
placement on study and subsequent receipt of any drug or experimental treatments.
Auditory Brainstem Response (ABR) Evaluations
All animals underwent bilateral ABR evaluations at 32 kHz prior to study
initiation (at least 14 days post-surgery), and at 3 and 24 hours following dosing. The
sound presentation was generated using an RZ6 multi I/O processor (TDT Technologies,
FL). The animals were anesthetized with an intraperitoneal drug combination of 40
mg/kg ketamine hydrochloride (100 mg/ml) and 0.25 mg/kg of dexmedetomidine (0.5
mg/ml). Once a stable plane of anesthesia was confirmed as a lack of pain response, the
animals were placed in the prone position within an electrically shielded sound
attenuation chamber. Pin lead wires were placed to collect the ABR biopotential data.
The lead configuration used to collect the electrophysiological data consisted of a
positive lead under the target ear, a reference lead at the vertex of the skull, and a ground
lead under the contralateral ear. The terminal ends of the pin leads were connected to a
Medusa preamplifier with a 20X gain and a 4-channel headstage (TDT Technologies,
FL). The stimulus used to elicit the ABR waveform was a 15 ms pure tone pip with a 1
ms rise/fall time. The 32 kHz tone was delivered at a rate of 10 cycles per second
through a MF-1 transducer (TDT Technologies, FL). The stimulus intensity was
attenuated in 10 dB steps beginning at 80 dB SPL. The biopotential data were averaged
across the 512 stimulus presentations for each intensity level. An auditory threshold was
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established by determining the level of activity that was 5 dB higher than the sound
pressure level that induced no recognizable elements comprising an ABR waveform.
Tissue Processing
The day following the final ABR evaluation, all animals were euthanized via
carbon dioxide inhalation. Whole body intracardiac perfusion was performed by the
application of 0.9% saline followed by 4% w/v paraformaldehyde. The temporal bones
from each animal were harvested. A small hole was made in the apex of each cochlea
and the oval window was perforated to facilitate intrascalar perfusion of 0.5%
paraformaldehyde. The cochleae were then stored in a solution of 0.5%
paraformaldehyde and placed in refrigerated conditions (2 - 8°C) overnight.
The cochleae were dissected to reveal the organ of Corti. To label the presynaptic
ribbons, postsynaptic glutamate receptors, and the auditory hair cells, the organ of Corti
were first placed in a blocking solution consisting of 1% goat serum (Invitrogen, CA) and
0.3% Triton X-100 in phosphate buffered saline (PBS) with calcium and magnesium.
The cochleae were then incubated overnight in a primary antibody solution comprised of
1:100 mouse anti-CtBP2 antibody (BD Transduction Laboratories, CA) and 1:100 rabbit
anti-GluR2/3 polyclonal antibody (Millipore, MA). After rinsing, the cochleae were then
incubated for an hour in a secondary antibody solution containing 1:200 Alexa Fluor®
488 Goat anti-mouse IgG (H+L) antibody (Life Technologies, CA), 1:200 Alexa Fluor®
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568 goat anti-rabbit IgG (H+L) antibody (Life Technologies, CA), and 1:200 Alexa
Fluor® 568 phalloidin (Life Technologies, CA).
Imaging and Analysis
All fixed and stained tissue slide imaging was conducted using a Zeiss Axiovert
200M confocal microscope at 63X magnification. The organ of Corti was first evaluated
to quantify the proportion of missing hair cells. The missing outer and inner hair cells
were assessed in 0.14 mm segments using a reticule, beginning in the apex and moving
toward the basal turn. Hair cell counts were then entered into Cytogram v3.0.6 to
generate average left and right ear cytocochleograms.
The organs of Corti were separated into 0.98 mm segments for the purposes of
locational analysis. The regions corresponding to 6.86, 15.68, 16.66, 17.64, 18.24, and
19.6 mm from apex were selected for confocal imaging based on historical data revealing
drug sensitivity within these regions. For image capture, z-stacks were created using a
0.4 µm step size. The images were deconvolved and saved as individual planes. Each
plane per region was then imported into ImageJ v1.47t for 3D reconstruction. A 3D
project was created for each region allowing 90 degree rotation at the x-axis of the 3D
image. Using the cell counter plugin, the number of co-localized CtBP2 and GluR2/3
puncta, each representing a functional synapse, were manually counted at the base of
each inner hair cell. A synapse density per inner hair cell was then calculated for each
region.
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Statistical Analyses
The ABR data and ribbon density measures are presented as mean ± S.D. The
ABR data averages were analyzed for significant differences between pretest and the 3
and 24 hours intervals using repeated measure analysis of variance with Tukey post hoc
tests in Graphpad Prism v4.00. The inner hair cell synapse density measurements for
each region were compared between the control and gentamicin treated ears using student
t-tests in Graphpad Prism v4.00.
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Results
Auditory Brainstem Response Evaluations
As shown in figure 19, the 32 kHz mean pretest threshold for the left ear was
21.25 ± 7.50 dB SPL. Three hours after administration of 50 µL of saline, the mean
threshold in the left ear increased to 33.75 ± 18.87 dB SPL. This increased threshold was
attributed to the presence of fluid in the middle ear as the average threshold returned to
21.25 ± 6.29 dB SPL 24 hours following administration.
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Figure 19. The average 32 kHz auditory threshold for the right (gentamicin-treated) ear
and left (saline-treated) ear presented by time interval.

The 32 kHz mean pretest threshold in the right ear was 26.25 ± 7.50 dB SPL.
Three hours following the administration of the 40 mg dose of gentamicin, the mean right
ear threshold significantly increased to 53.75 ± 14.36 dB SPL. By 24 hours, this
threshold shift further increased in the right ear to 75.00 ± 9.13 dB SPL indicating the
presence of gentamicin induced sensorineural hearing loss.
Cytocochleogram Analysis
The average hair cell data for each group is presented in figure 20. The hair cell
analysis demonstrated that saline control injections had no effect on the viability of the
outer or inner hair cells throughout the entire organ of Corti. Gentamicin, however,
produced a robust cytotoxic effect on outer hair cells engendering losses of 40% 10 mm
from apex, and increasing to 100% beginning 14 mm from apex. Inner hair cell losses
were minimal throughout the organs of Corti until a point approximately 19 mm from
apex where the percentage of hair cell loss increased above 40%. Interestingly, in the
region 4mm to 8 mm from apex, outer hair cell losses were below 20%.
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Figure 20. % missing hair cells following direct middle administration of gentamicin.

Inner Hair Cell Synapse Density
The average inner hair cell synapse densities from selected regions of the organ of
Corti collected from the left saline control treated ear 24 hours subsequent to
administration:
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Distance from Apex (mm) Synapses per Hair Cell
6.86
14.57 ± 1.55
15.68
17.27 ± 3.09
16.66
14.83 ± 3.91
17.64
14.65 ± 1.56
18.62
13.25 ± 1.93
19.60
12.84 ± 1.73

The average inner hair cell synapse densities from selected regions of the organ of
Corti collected from the right gentamicin treated ear 24 hours subsequent to
administration:
Distance from Apex (mm) Synapses per Hair Cell
6.86
12.54 ± 3.35
15.68
4.10 ± 2.23
16.66
4.38 ± 3.61
17.64
4.56 ± 2.28
18.62
3.07 ± 0.92
19.60
3.09 ± 0.41

There were no significant differences in the average synapse density between the
saline and gentamicin treated ears as evaluated 6.86 mm from apex region. As shown in
figure 2, the gentamicin treatment significantly decreased the synapse density by 76% in
the 15.68 mm region (p=0.0001), 70% in the 16.66 mm region (p=0.001), 69% in the
17.64 mm region (p=0.00004), 77% in the 18.24 mm region (p=0.00003), and 76% in the
19.6 mm region (p=0.005). By comparing the synaptic densities of the corresponding
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hair cell data in these regions to the hair cell and synaptic density in the 6.86 mm region,
it appears that the decreases in inner hair cell synaptic densities occurred in regions that
have greater outer hair cell damage. Interestingly moderate to no inner hair cell losses
were detected.
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Figure 21. (21A) Inner hair synapse density following direct middle ear administration
of gentamicin Representative image of inner hair cells with associated ribbon synapses in
(21A) control and (21B) treated tissues.
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Discussion
The results of this study show that intra-aural gentamicin produces severe inner
hair cell synaptopathy acutely following dosing. While there is severe auditory
dysfunction and outer hair cell loss incurred, there is only minimal inner hair cell loss
observed. The synaptopathy following intra-aural gentamicin began at 15.6 mm from
apex, not-surprisingly indicating greater neurotoxicity compared to systemic kanamycin,
which showed effects beginning at 17.6 mm from apex. These results suggest that
compounds within the aminoglycoside class of compounds are synaptotoxic in the inner
ear, and also that intra-aural administration of these compounds may allow greater drug
exposure and subsequently affect a larger area within the cochlea.
The use of middle ear catheters to directly administer drug formulations to the
round window allows for a higher concentration of drug exposure within the perilymph
as compared to systemic routes. Administration by systemic routes leads to variable
concentrations of aminoglycosides within the cochlea due to metabolic and distributional
confounds, which subsequently produces corresponding local variability in neuronal
viability. Employment of the transtympanic route in this study allowed for collection of
data towards a comprehensive and definitive modeling of the acute oto-neurotoxic effects
of gentamicin.
We reported that high doses of systemic kanamycin produce decreases in inner
hair cell synapse densities in the lower basal regions of the cochlea. Intra-aural
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gentamicin produced a greater quantitative reduction in synapse density, and also affected
more of the apical regions of the cochlea. This suggests that the inner hair cell synapse
losses observed are directly correlated to the effective drug exposure within the inner ear.
The inner hair cells in both studies were largely unaffected by the drug treatment,
implying that these drugs alter the inner hair cell function or directly causes the
deterioration of the ribbon synapse. The ribbon synapse decreases observed arise largely
in the basal region of the cochlea where severe outer hair cell losses occur. It has been
shown that the hair cells in the basal region of the cochlea are more sensitive to drug
treatment as a result of decreased endogenous mechanisms for handling cellular stress
(Sha et al., 2001).
The synaptopathy observed in this study is relevant for patients being treated for
Meniere’s disease. Most studies conducted on gentamicin-treated Meniere’s patients
report that hearing loss is observed in the minority of patients if the treatment is
monitored closely (Silverstein et al., 2010). Kujawa and Liberman (2009) found that
noise exposures producing temporary threshold increases induced permanent inner hair
cell synapse degeneration and long term spiral ganglion loss. Although threshold
sensitivity is preserved, supra-threshold wave I amplitude is drastically reduced,
impacting long term selective auditory attention (Bharadwaj et al., 2014, Furman et al.,
2013, Demanez et al., 2003). We have shown that aminoglycoside-induced synaptopathy
is at least partially recoverable, but the long term ramifications on spiral ganglion
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degeneration have not been assessed. If these here to fare considered “safe” doses of
gentamicin are producing recoverable synaptopathic insults, the long term effects may
mimic those same supra-threshold hearing deficits observed with noise exposures.
In conclusion, this study confirmed that aminoglycosides produce significant
decreases in inner hair cell synapses acutely following intra-aural administration, which
is variably recoverable. Additionally, a clinically relevant, 10 mg dose produced more
widespread synaptic damage in the cochlea than that observed with systemic
aminoglycoside administration. These results suggest that caution should be use when
using aminoglycoside treatments via the transtympanic route as the long term
repercussions of synaptic loss have not be evaluated and may contribute to long term
hearing deficits.
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CHAPTER VI
DISSERTATION SUMMARY AND CONCLUSIONS
The aims of this dissertation project were to elucidate the effects of
aminoglycosides on synaptic plasticity. We were first able to determine that high
systemically administered doses of kanamycin produce significant effects on inner hair
cell ribbon densities in the base of the cochlea. Building upon these results, we
determined that the observed reduction in inner hair cell ribbon density occurred only
acutely followed by a period of apparent partial recovery. Up to this point in the project,
we had analyzed only presynaptic structures; therefore the next project examined both
pre- and post-synaptic structures and the effect of kanamycin on their co-localization.
These experimental results clearly confirmed that aminoglycoside therapy produced a
partially recoverable synaptopathic insult. Our final experiment looked at how direct
administration of aminoglycosides to the middle ear affected synapse plasticity. This
experiment showed that direct administration of aminoglycosides produced significantly
more synaptic degeneration and also affected more of the cochlea as compared to
systemic administration. Of the greatest potential significance was the discovery that
inner hair cell ribbon synapse degeneration is recoverable.
These results have several implications with regard to enhancing preventative
therapies to prevent aminoglycoside-induced hearing loss in humans. Identification of
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the effects of aminoglycoside antibiotics on synapse degeneration supports the role of
excitotoxicity as a mechanism associated with hair cell death. Substantial work will be
required to establish the proper NMDA antagonist compound and relative efficacious
dose concentration that will provide sufficient protection. In all likelihood, a
combination therapy consisting of antioxidants and NMDA antagonists will be required
to provide complete protection from aminoglycoside damage. One challenge in
designing a co-therapy to be administered along with an aminoglycoside will be that the
patient will have compromised kidney function. The kidney is critical for drug
metabolism and thus compromised function may consequently exacerbate damage as
aminoglycoside concentrations will be maintained at high concentrations for a longer
duration. In spite of these challenges, our results provide insight into the mechanisms
involved in aminoglycoside ototoxicity and could help direct future protective therapies.
The finding that kanamycin-induced synaptopathy is recoverable is impactful and
significant in the field of otolaryngology. As reiterated multiple times in this dissertation,
the finding that synaptopathies are recoverable in guinea pigs provides hope that the same
effect may be observed in humans. Before any clinical advances can occur, additional
research must be conducted to better understand the processes that are involved in this
regenerative process. Additionally, the function and sustainability of these new synapses
must be determined to understand the implications of inducing re-innervation in patient
populations.
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Understanding why regeneration occurs in guinea pigs and not mice would
provide the necessary information on how to approach inducing re-innervation as a
therapy. Future research should focus on quantifying the expression of various nerve
growth factors, such as NT-3 and BDNF, during the re-innervation process. It has been
shown that these specific growth factors help induce synaptogenesis following cochlear
trauma (Wang and Green, 2011). Studies should focus on the endogenous expression of
these nerve growth factors in the cochlea of mice and guinea pigs to understand if there is
a differential expression in each species. A differential level of endogenous nerve growth
factors, with higher levels being expressed in guinea pigs, would strongly support why
re-innervation occurs in the guinea pig and not in mice. It was recently shown that mice
genetically modified to overexpress NT-3 were capable of regenerating synapses
following a mild noise exposure (Wan et al., 2014). This recent finding further supports
that expression of these nerve growth factors is critical for re-innervation in the cochlea.
Using the aminoglycoside model of synaptic re-innervation, it should also be determined
if NT-3 expression is upregulated immediately following kanamycin administration
during re-innervation. These data would support the development of an exogenous NT-3
therapy to promote synaptogenesis following cochlear trauma.
Future research should also focus on characterizing auditory function following
synaptic re-innervation. Liu et al. (2013) found that temporal resolution, as defined by
the ability to process multiple click stimuli during ABR evaluations, was not restored in
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spite of recovery of auditory threshold and synaptic re-innervation. Other research has
shown that mild noise overexposure produces transient threshold increases with
associated synaptic loss, but in recovery the supra-threshold neural amplitude of the ABR
wave I, associated with cochlear neurotransmission, is significantly reduced (Kujawa and
Liberman, 2009). This effect has been further examined showing that the high threshold,
low spontaneous rate subset of afferent cochlear neurons is highly susceptible to noise
exposure (Furman et al., 2013). The afferent dendrites have been shown to have different
afferent neuron populations that are activated by different intensity levels (Kantardzhieva
et al., 2013, Liberman et al., 2011). If there appears to be a sub-population of afferent
neurons that are sensitive to noise, it should also be determined if there are a subpopulation of afferent neurons that are sensitive to aminoglycoside treatment.
The aminoglycoside-induced synaptopathy model is challenging to assess neural
function via ABR due to the severe outer hair cell losses observed following treatment.
The outer hair cells provide amplification of sound waves within the cochlea and
therefore a reduction in the suprathreshold wave I amplitude may be due to a loss of hair
cell function and not correlated with a loss of synaptic connections. An alternative
method to assess the impact of re-innervation of temporal resolution and wave I neural
amplitude would be to use an electrically evoked auditory brainstem response (eABR).
The use of eABRs following aminoglycoside treatment would allow for the monitoring of
inner hair cell neurotransmission during re-innervation. eABRs are used clinically to
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determine residual auditory nerve function in patients looking to receive a cochlear
prosthetic device.
To determine if sub-populations of the afferent neurons are affected by
kanamycin treatment, single unit nerve fiber recordings would need to be conducted
following treatment. This is consistent with the procedures that were used to determine
the subpopulation of afferent nerve fibers that were most sensitive to noise overexposure.
Characterization of afferent nerve fiber sensitivity following kanamycin administration
would provide insight into potential contributing factors to the hearing loss observed
following aminoglycoside ototoxicity. Furthermore, this data may help to determine if
there is a sub-population of afferent nerve fibers, such as the high threshold fiber, that are
sensitive to cochlear damage in general. If found that a sub-population of afferent
neurons is most vulnerable to cochlear trauma, identification of the cause could help
provide a therapeutic target to reduce neurodegeneration.
Future research should also be directed at evaluating the long term effects of
synaptic loss and regeneration in the guinea pig. In the mouse it has been shown that a
cochlear injury resulting in synaptic loss results in a secondary effect of spiral ganglion
degeneration beginning approximately 1 year from the initial insult (Kujawa and
Liberman, 2009). The same effect was not observed in the guinea pig following synaptic
loss as assessed at 6 months and 1 year following injury (Liu et al., 2013; Lin et al.,
2011). The lack of this effect could be explained by the relative differences in life span
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which could contribute to the difference in timing of secondary degeneration, or may also
be explained by the presence of synaptic re-innervation which would maintain spiral
ganglion neuron viability. Therefore conducting a study using kanamycin-induced
synaptopathy in guinea pigs that assessed auditory function, synaptic density, and spiral
ganglion degeneration over a 2 year time-course would provide clarity on the long-term
implications of synaptic re-innervation on restoration of auditory function. This data
could provide insight into approaches to help restore auditory function in patients with
long term hearing dysfunction.
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